var title_f20_27_20912="Hand-foot-and-mouth disease - tongue";
var content_f20_27_20912=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F71314&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F71314&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hand-foot-and-mouth disease - tongue",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple small ulcers are present on the tongue.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20912=[""].join("\n");
var outline_f20_27_20912=null;
var title_f20_27_20913="Cephalic view of clavicle fracture";
var content_f20_27_20913=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F65790&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F65790&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 586px\">",
"   <div class=\"ttl\">",
"    Cephalic view of clavicle fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 566px; height: 274px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This midshaft clavicle fracture cannot be appreciated with standard views (radiograph on left).&nbsp;However,&nbsp;by using&nbsp;the 45-degree cephalic tilt view (radiograph on right), bone&nbsp;angulation and a fracture line become apparent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Eiff, MP, Hatch, RL, Calmbach, W (Eds). Fracture Management for Primary Care, 2nd Edition, W.B. Saunders Company, Philadelphia 2002. Illustration used with permission of Elsevier Inc. All right reserved. Copyright &copy;2002 Elsevier Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20913=[""].join("\n");
var outline_f20_27_20913=null;
var title_f20_27_20914="Cystic fibrosis PI";
var content_f20_27_20914=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F74980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F74980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 499px\">",
"   <div class=\"ttl\">",
"    Organs most affected by cystic fibrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 479px; height: 522px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cystic fibrosis is a disease that some children are born with. It causes thick mucus and other fluids to build up and clog different parts of the body, including the lungs, pancreas, liver, and intestine.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20914=[""].join("\n");
var outline_f20_27_20914=null;
var title_f20_27_20915="Structureless areas";
var content_f20_27_20915=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F69773&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F69773&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermoscopy of structureless lesions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 338px; height: 550px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Hypopigmented and (B) heavily pigmented structureless lesions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20915=[""].join("\n");
var outline_f20_27_20915=null;
var title_f20_27_20916="Liver phosphorylase deficiency (glycogen storage disease VI, Hers disease)";
var content_f20_27_20916=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Liver phosphorylase deficiency (glycogen storage disease VI, Hers disease)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20916/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20916/contributors\">",
"     William J Craigen, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20916/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20916/contributors\">",
"     Sihoun Hahn, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20916/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20916/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/27/20916/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of inborn errors of glycogen metabolism that result from mutations in genes for virtually all of the proteins involved in glycogen synthesis, degradation, or regulation. Those disorders that result in abnormal storage of glycogen are known as glycogen storage diseases (GSDs). They have largely been categorized by number according to the chronology of recognition of the responsible enzyme defect (",
"    <a class=\"graphic graphic_table graphicRef54417 \" href=\"UTD.htm?37/36/38477\">",
"     table 1",
"    </a>",
"    ). Liver phosphorylase deficiency (GSD VI, MIM #232700), also known as Hers disease, is usually a mild form of glycogenosis; however, severe hepatomegaly and recurrent severe hypoglycemia have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/1\">",
"     1",
"    </a>",
"    ]. It is due to deficiency of the liver isoform of phosphorylase.",
"   </p>",
"   <p>",
"    Liver phosphorylase deficiency is reviewed here. Other glycogen storages diseases are reviewed separately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9435862\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glycogen is the stored form of glucose and serves as a buffer for glucose needs. Glycogen is formed in periods of dietary carbohydrate loading and broken down when glucose demand is high or dietary availability is low (",
"    <a class=\"graphic graphic_figure graphicRef81164 \" href=\"UTD.htm?4/62/5089\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Glycogen is most abundant in liver and muscle, which are most affected by disorders of glycogen metabolism. The physiologic importance of a given enzyme in liver and muscle determines the clinical manifestations of the disease. The main role of glycogen in the liver is to store glucose for release to tissues that are unable to synthesize significant amounts during fasting. The major manifestations of disorders of glycogen metabolism affecting the liver are hypoglycemia and hepatomegaly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=see_link\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A more extensive overview of glycogen storage disease is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/16/4356?source=see_link\">",
"     \"Overview of inherited disorders of glucose and glycogen metabolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9435888\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of GSD VI is unknown. It is rare in the general population, although it is probably underdiagnosed because of its typically more indolent course compared with other GSDs. GSD VI and IX (deficiencies of liver phosphorylase and the enzyme that regulates its activity, respectively) together account for 25 to 30 percent of all the GSDs, with an estimated prevalence of 1 in 100,000. Most of these are GSD type IX. The disease frequency is 1 in 1000 in a Pennsylvanian Mennonite population with a founder mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Genetics'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9435904\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;GSD VI is due to a deficiency of liver phosphorylase. Liver glycogen phosphorylase catalyzes the cleavage of a-1,4- glucosidic bonds to release glucose 1-phosphate from glycogen (",
"    <a class=\"graphic graphic_figure graphicRef81164 \" href=\"UTD.htm?4/62/5089\">",
"     figure 1",
"    </a>",
"    ). Enzyme activity is regulated by phosphorylation by phosphorylase kinase, the deficiency of which causes GSD IX. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25237?source=see_link\">",
"     \"Phosphorylase b kinase deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;GSD VI is an autosomal recessive disorder. It is caused by mutations in the gene for the liver isoform of phosphorylase (PGYL), located at 14q21. Missense, nonsense, and splice site mutations have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/3,4\">",
"     3,4",
"    </a>",
"    ], although the frequency of null mutations appears less than other GSDs [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/5\">",
"     5",
"    </a>",
"    ]. A founder mutation involving a splice site alteration was identified in a Pennsylvanian Mennonite population [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients typically present in early childhood with the characteristic features of growth retardation and prominent hepatomegaly [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/6\">",
"     6",
"    </a>",
"    ]. Most have mild hypoglycemia, hyperlipidemia, and ketosis, although occasional patients have more significant hypoglycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/5\">",
"     5",
"    </a>",
"    ]. Hypoglycemia and ketosis typically occur after an overnight fast or after prolonged daytime fasting, such as during an illness. Skeletal and cardiac muscle are not affected. Intellectual development is normal in most cases. The patient may develop osteoporosis if the disease is untreated. Manifestations improve with puberty, with a decrease in hepatomegaly and improvement in growth with attainment of normal adult height [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9435920\">",
"    <span class=\"h1\">",
"     LABORATORY FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients often have mildly elevated concentrations of serum transaminases and hyperlipidemia. Plasma concentrations of uric acid are usually normal, although postprandial lactic acidemia is observed. Biotinidase activity is increased and may be a sensitive biomarker [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/7\">",
"     7",
"    </a>",
"    ]. The activity of serum creatine kinase is normal. Glucose levels do not increase following administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/32/25093?source=see_link\">",
"     glucagon",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of liver phosphorylase deficiency should be considered in a child with unexplained hepatomegaly and ketosis with mildly elevated transaminases. A fasting glucose and test for ketones should be performed, with the caveat that the child needs to be monitored closely if GSDI is being considered because of the risk of significant hypoglycemia. GSD IX is more common and presents similarly to GSD VI, but is primarily X-linked. Thus, molecular testing of the gene responsible for GSD VI (PGYL) is done first if the patient is female. Testing of the gene responsible for GSD IX (PHKA2) is done first if the patient is male.",
"   </p>",
"   <p>",
"    The diagnosis can also be confirmed by reduced or absent enzyme activity in liver tissue, but enzyme activity can be affected by other factors, leading to erroneous results. Assay of enzyme activity can be performed on erythrocytes and leukocytes. However, false negatives (normal enzyme activity detected) are common because the deficiency is isolated to the liver. Thus, molecular testing for PYGL gene mutations is the preferred confirmatory diagnostic tool [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/8\">",
"     8",
"    </a>",
"    ]. For the Mennonite population, it is only necessary to test for the one mutation found specifically in that group. For others, sequencing of the gene is necessary.",
"   </p>",
"   <p>",
"    Liver biopsy with assay of enzyme activity is performed if molecular testing is nondiagnostic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9435928\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phosphorylase b kinase (PBK) is necessary for activation of liver glycogen phosphorylase. Thus, PBK deficiency (GSD IXb) has a similar clinical presentation to GSD VI. However, the response to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/32/25093?source=see_link\">",
"     glucagon",
"    </a>",
"    is normal in GSD IXb, unlike GSD VI. In addition, the majority of cases of PBK deficiency are X-linked. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25237?source=see_link\">",
"     \"Phosphorylase b kinase deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hypoglycemia is usually more severe in GSD I. In addition, fasting serum lactate is elevated in GSD I and normal in GSD VI. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/48/16136?source=see_link\">",
"     \"Glucose-6-phosphatase deficiency (glycogen storage disease I, von Gierke disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    GSD III presents with hypoglycemia and hepatomegaly, but most of these children also have skeletal muscle weakness associated with an elevated serum CK. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/34/13861?source=see_link\">",
"     \"Glycogen debrancher deficiency (glycogen storage disease III)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with hypoglycemia should have frequent high-carbohydrate feedings. Alternatively, uncooked cornstarch can be used at a dose of 1 to 2",
"    <span class=\"nowrap\">",
"     gm/kg",
"    </span>",
"    per dose, between meals and at bedtime. The bedtime dose is generally higher than the between meal doses. Young infants (&lt;six months) may develop gastrointestinal distress (colicky symptoms or diarrhea) with cornstarch administration because pancreatic amylase has not reached normal adult level. Preprandial glucose monitoring is useful in adjusting therapy. Treatment with cornstarch may improve growth, hepatomegaly, bone density, serum analytes, and stamina due to better metabolic control, even in patients without hypoglycemic episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/1\">",
"     1",
"    </a>",
"    ]. A pregnant woman with GSD VI should have her blood glucose monitored. Bone density testing should be assessed once the individual has stopped growing [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9435896\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The disease typically has a benign course and improves with age, although hypoglycemia can occur during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/1\">",
"     1",
"    </a>",
"    ]. Hepatomegaly resolves in most cases. Patients may be at increased risk for developing hepatic tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20916/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Liver ultrasound to screen for hepatic adenoma should be performed annually beginning around 10 years of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9435936\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Liver phosphorylase deficiency, also called glycogen storage disease type VI (GSD VI), is caused by mutations in the gene for the liver isoform of glycogen phosphorylase (PGYL). (See",
"      <a class=\"local\" href=\"#H9435904\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Genetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients typically present in early childhood with the characteristic features of growth retardation, prominent hepatomegaly, mild hypoglycemia, and ketosis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Molecular testing for PYGL gene mutations is the preferred confirmatory diagnostic tool. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Phosphorylase b kinase deficiency (GSD IXb) has a similar clinical presentation to GSD VI. However, the response to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/32/25093?source=see_link\">",
"       glucagon",
"      </a>",
"      is normal in GSD IXb, unlike GSD VI. (See",
"      <a class=\"local\" href=\"#H9435928\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9435920\">",
"       'Laboratory findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients are treated with uncooked cornstarch between meals and at bedtime to prevent hypoglycemia and ketosis. Treatment may improve growth, hepatomegaly, bone density, serum analytes, and stamina. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The disease typically has a benign course and improves with age. However, patients may be at increased risk for hepatic tumors. (See",
"      <a class=\"local\" href=\"#H9435896\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     GeneReviews: Glycogen Storage Disease Type VI file://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/books/NBK5941/?&amp;log$=disease6_name (Accessed on July 13, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20916/abstract/2\">",
"      Chang S, Rosenberg MJ, Morton H, et al. Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI. Hum Mol Genet 1998; 7:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20916/abstract/3\">",
"      Burwinkel B, Bakker HD, Herschkovitz E, et al. Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. Am J Hum Genet 1998; 62:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20916/abstract/4\">",
"      Tang NL, Hui J, Young E, et al. A novel mutation (G233D) in the glycogen phosphorylase gene in a patient with hepatic glycogen storage disease and residual enzyme activity. Mol Genet Metab 2003; 79:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20916/abstract/5\">",
"      Beauchamp NJ, Taybert J, Champion MP, et al. High frequency of missense mutations in glycogen storage disease type VI. J Inherit Metab Dis 2007; 30:722.",
"     </a>",
"    </li>",
"    <li>",
"     Chen YT. Glycogen storage diseases. In: The metabolic and molecular bases of inherited disease, 8th ed, Scriver CR, Beaudet AL, Sly WS, Valle D (Eds), McGraw Hill, New York 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20916/abstract/7\">",
"      Paesold-Burda P, Baumgartner MR, Santer R, et al. Elevated serum biotinidase activity in hepatic glycogen storage disorders--a convenient biomarker. J Inherit Metab Dis 2007; 30:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20916/abstract/8\">",
"      Davit-Spraul A, Piraud M, Dobbelaere D, et al. Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies. Mol Genet Metab 2011; 104:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20916/abstract/9\">",
"      Ogawa A, Ogawa E, Yamamoto S, et al. Case of glycogen storage disease type VI (phosphorylase deficiency) complicated by focal nodular hyperplasia. Pediatr Int 2010; 52:e150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20916/abstract/10\">",
"      Manzia TM, Angelico R, Toti L, et al. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. Transplant Proc 2011; 43:1181.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2944 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-F0948400E7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20916=[""].join("\n");
var outline_f20_27_20916=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9435936\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9435862\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9435888\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9435904\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9435920\">",
"      LABORATORY FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9435928\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9435896\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9435936\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2944\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2944|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/62/5089\" title=\"figure 1\">",
"      Pathways of glycogen metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2944|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/36/38477\" title=\"table 1\">",
"      Disorders of glycogen - glucose metabolism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/48/16136?source=related_link\">",
"      Glucose-6-phosphatase deficiency (glycogen storage disease I, von Gierke disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/34/13861?source=related_link\">",
"      Glycogen debrancher deficiency (glycogen storage disease III)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/16/4356?source=related_link\">",
"      Overview of inherited disorders of glucose and glycogen metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25237?source=related_link\">",
"      Phosphorylase b kinase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=related_link\">",
"      Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_27_20917="Pemphigus foliaceus DIF";
var content_f20_27_20917=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82838&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82838&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus foliaceus direct immunofluorescence",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Intercellular antibody binding is evident within the upper epidermis in this direct immunofluorescence specimen from a patient with pemphigus foliaceus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kristin M Leiferman, MD, Immunodermatology Laboratory, Department of Dermatology, University of Utah, Salt Lake City, Utah.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20917=[""].join("\n");
var outline_f20_27_20917=null;
var title_f20_27_20918="Microbiology, epidemiology, and pathogenesis of Bordetella pertussis infection";
var content_f20_27_20918=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Microbiology, epidemiology, and pathogenesis of Bordetella pertussis infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20918/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20918/contributors\">",
"     Paul Cornia, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20918/contributors\">",
"     Benjamin Lipsky, MD, FACP, FIDSA, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20918/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20918/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20918/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20918/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20918/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/27/20918/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 12, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H252274975\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pertussis, also known as &ldquo;whooping cough,&rdquo; is a highly contagious, acute respiratory illness caused by Bordetella pertussis. Sydenham is credited with naming the illness pertussis in 1679, from the Latin term meaning &ldquo;intense cough.&rdquo; In addition, the Chinese term for pertussis translates to &ldquo;the 100-day cough.&rdquo; These names describe the key clinical features of infection. However, the classic clinical manifestations of pertussis infection (cough with paroxysms, inspiratory whoop, and post-tussive emesis) are frequently absent in adolescents and adults.",
"   </p>",
"   <p>",
"    The microbiology, pathogenesis, and epidemiology of pertussis are reviewed here. The clinical manifestations, diagnosis, management, and prevention of pertussis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13911?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/14/25833?source=see_link\">",
"     \"Treatment and prevention of Bordetella pertussis infection in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16248?source=see_link\">",
"     \"Clinical features and diagnosis of Bordetella pertussis infection in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H270844\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pertussis is caused by the gram-negative coccobacillus Bordetella pertussis, a strict human pathogen with no known animal or environmental reservoir [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/1\">",
"     1",
"    </a>",
"    ]. The organism is fastidious, surviving only a few hours in respiratory secretions, and thus requiring special media for culture.",
"   </p>",
"   <p>",
"    Eight additional Bordetella species have been described: B. parapertussis",
"    <sub>",
"     hu",
"    </sub>",
"    , B. parapertussis",
"    <sub>",
"     ov",
"    </sub>",
"    (ovine-adapted parapertussis), B. bronchiseptica, B. avium, B. hinzii, B. holmesii, B. trematum, and B. petrii [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/2\">",
"     2",
"    </a>",
"    ]. Three of these species (B. parapertussis, B. bronchiseptica, and B. holmesii)",
"    <sub>",
"    </sub>",
"    can cause respiratory illness in humans. B. parapertussis may cause a spectrum of disease ranging from a nonspecific upper respiratory tract illness to classic pertussis (ie, clinically indistinguishable from that of B. pertussis) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/3\">",
"     3",
"    </a>",
"    ]. B. bronchiseptica causes respiratory infections in a variety of mammals; infection in humans can occur in immunocompromised hosts with animal exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/4\">",
"     4",
"    </a>",
"    ]. B. holmesii infection has been described in the setting of septicemia and respiratory infection clinically similar to classic pertussis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/5-7\">",
"     5-7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H252274996\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pertussis is a highly contagious respiratory illness. In adolescents and adults, infection may result in a protracted cough and is occasionally associated with substantial morbidity. In children, and particularly infants, morbidity can be substantial and the disease may be fatal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H252275003\">",
"    <span class=\"h2\">",
"     Transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incubation period for B. pertussis ranges from one to three weeks, but is most typically 7 to 10 days. This is in contrast to the shorter incubation period (one to three days) for non-specific viral upper respiratory infection cough illnesses, such as the common cold. Pertussis infection is spread via respiratory droplets, which are effectively aerosolized by the paroxysms of coughing [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/8\">",
"     8",
"    </a>",
"    ]. In a household contact study, approximately one-third of exposed household subjects developed pertussis; nearly one-half of asymptomatic subjects also had laboratory evidence of infection, and the remainder had a mild respiratory illness (ie, non-classical symptoms of pertussis) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/9\">",
"     9",
"    </a>",
"    ]. Thus, asymptomatic infection is common, but spread of infection is unlikely in the absence of cough. Individuals with pertussis are considered infectious until they have completed five days of appropriate antibiotic treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H252275010\">",
"    <span class=\"h2\">",
"     Incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pertussis was a devastating illness with a relatively high infant mortality rate prior to the introduction of a whole-cell vaccine in the United States in the late 1940s. Widespread pertussis vaccination of children led to a dramatic decline in disease incidence, from a peak of more than 250,000 reported cases in 1934 to a nadir of 1010 cases in 1976 (",
"    <a class=\"graphic graphic_figure graphicRef83297 \" href=\"UTD.htm?28/48/29454\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/13\">",
"     13",
"    </a>",
"    ]. Since that time, there has been a steady increase in reported cases in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/14\">",
"     14",
"    </a>",
"    ]; in 2010 there were 27,550 reported cases and outbreaks in several states (",
"    <a class=\"graphic graphic_figure graphicRef73317 \" href=\"UTD.htm?34/14/35053\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, cyclical epidemics occur every two to five years; this cyclic epidemic pattern was also present in the pre-vaccine era. These cyclical epidemics have been superimposed on the steadily rising incidence in the United States and many other developed countries. The unchanged cyclical epidemic pattern suggests that the overall circulation of B. pertussis in the population has not been affected by the vaccine [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cause for the rising incidence of pertussis is not fully understood. Possible explanations include: increased clinician awareness, increased public health reporting, increased availability of more sensitive diagnostic tests (particularly polymerase chain reaction [PCR]), waning vaccine-induced immunity in adolescent populations (immunity following vaccine or infection is not lifelong) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/18\">",
"     18",
"    </a>",
"    ], decreased use of pertussis vaccine, and a true increase in circulating B. pertussis. The most important factors appear to be increased awareness and better diagnostic tests [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Worldwide, 90 percent of the 30 million to 50 million annual cases of pertussis occur in developing countries; about 300,000 cases result in death [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/21\">",
"     21",
"    </a>",
"    ]. Mortality occurs predominantly in infants (too young to have received vaccination) and unvaccinated or under-vaccinated children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H252275017\">",
"    <span class=\"h2\">",
"     Evolving epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, a substantial portion of the increasing incidence in reported pertussis cases since 1990 is attributable to increased rates of infection in adolescents and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/22-25\">",
"     22-25",
"    </a>",
"    ]. In the pre-vaccine era, more than 90 percent of reported cases of pertussis occurred in children &lt;10 years old [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/23\">",
"     23",
"    </a>",
"    ]. In the late 1990s, about one-half of reported cases occurred in adolescents and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/13\">",
"     13",
"    </a>",
"    ]. The incidence of reported pertussis cases among infants also increased between 1980 and 1999 [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Manifestations of pertussis in adolescents and adults are often less severe than in infants and children. The presence of classical symptoms and signs of pertussis (inspiratory whoop, paroxysmal cough, and post-tussive emesis) in adolescents and adults is only modestly useful in determining if a patient with prolonged cough has pertussis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/28\">",
"     28",
"    </a>",
"    ]. Nonetheless, B. pertussis infection in adolescents and adults appears to be much more common than many clinicians appreciate [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/16,19\">",
"     16,19",
"    </a>",
"    ]. Studies of adolescents and adults with cough illnesses lasting one week or longer in non-outbreak settings indicate that pertussis is responsible for 13 to 20 percent of cases; the overwhelming majority of patients actually had a substantially longer duration of illness (&gt;3 weeks) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/19,29\">",
"     19,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adolescents and adults with unrecognized pertussis are a reservoir of infection for infants and children [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/30\">",
"     30",
"    </a>",
"    ]. Groups at highest risk of pertussis-related morbidity and mortality include infants (especially those younger than six months) and young children who have not been fully immunized. Epidemiologic studies have shown that most infants acquire the infection from adolescents and adults in their own household [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/31-34\">",
"     31-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An important misconception is that childhood pertussis vaccination confers lifelong immunity. Protective immunity wanes after 5 to 10 years and rarely lasts more than 12 years [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Therefore, booster vaccination is recommended for adolescents and adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39271?source=see_link&amp;anchor=H5842133#H5842133\">",
"     \"Treatment and prevention of Bordetella pertussis infection in adolescents and adults\", section on 'Tdap booster'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7117016\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adults &gt;65 years are more likely to be hospitalized than younger adults. Obesity and preexisting asthma have been associated with a higher likelihood of pertussis diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H269764\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;B. pertussis is transmitted via aerosolized respiratory droplets. It produces a number of biologically active substances and virulence factors that promote cellular attachment, cause local tissue damage or systemic manifestations, and interfere with host defense mechanisms (",
"    <a class=\"graphic graphic_table graphicRef76173 \" href=\"UTD.htm?0/1/18\">",
"     table 1",
"    </a>",
"    ). After inhalation, the organism adheres to ciliated respiratory epithelial cells of the upper respiratory tract and nasopharynx. A variety of protein adhesins have been implicated in the attachment process; these demonstrate a substantial degree of redundancy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/2\">",
"     2",
"    </a>",
"    ]. Once attached, they induce local tissue damage via tracheal cytotoxin, dermonecrotic toxin, or adenylate cyclase; this destructive process, with loss of the protective respiratory cells, is likely responsible for the cough.",
"   </p>",
"   <p>",
"    Histopathological analysis of tissue samples obtained from cases of fatal pertussis infection in infants using a novel immunohistochemical technique noted intracellular organisms in alveolar macrophages as well as the ciliated respiratory epithelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/38\">",
"     38",
"    </a>",
"    ]. This may explain the prolonged duration of cough. The most notable systemic laboratory manifestation is lymphocytosis, which is caused by pertussis toxin (PT). PT may also cause hyperinsulinemia with resultant hypoglycemia in young infants [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following infection, antibodies to a variety of antigens develop, including pertussis toxin, filamentous hemagglutinin, pertactin, fimbriae",
"    <span class=\"nowrap\">",
"     2/3,",
"    </span>",
"    lipopolysaccharide, and adenylate cyclase. Many of these antigens form the components of pertussis vaccines. Several animal model studies suggest that cellular-mediated immunity complements the humoral response [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20918/abstract/41-44\">",
"     41-44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H252275031\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      B. pertussis is a fastidious, gram-negative coccobacillus that requires special media for culture. It is exclusively a human pathogen. (See",
"      <a class=\"local\" href=\"#H270844\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The incubation period for B. pertussis is typically one week, but may be three weeks or longer. (See",
"      <a class=\"local\" href=\"#H252275003\">",
"       'Transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The introduction of the whole-cell pertussis vaccine in the United States in the late 1940s led to a dramatic decline in disease incidence. Since the 1970s, however, the number of reported cases in the United States has been steadily rising, most likely because of increased awareness of the disease and better diagnostic tests. (See",
"      <a class=\"local\" href=\"#H252275010\">",
"       'Incidence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adolescents and adults with unrecognized pertussis represent a reservoir of infection for infants and children, in whom infection is associated with substantially higher morbidity and mortality. Booster vaccination of adolescents and adults is recommended. (See",
"      <a class=\"local\" href=\"#H252275017\">",
"       'Evolving epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      B. pertussis is highly contagious and is transmitted via aerosolized respiratory droplets. After inhalation, the organism adheres to ciliated respiratory epithelial cells of the upper respiratory tract and nasopharynx. (See",
"      <a class=\"local\" href=\"#H269764\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H252275812\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Christopher Ohl, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Cotter PA, Miller JF. Bordetella. In: Principles of bacterial pathogenesis, Groisman EA.  (Ed), Academic Press, Ltd, London 2001. p.619.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/2\">",
"      Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/3\">",
"      Cherry JD, Seaton BL. Patterns of Bordetella parapertussis respiratory illnesses: 2008-2010. Clin Infect Dis 2012; 54:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/4\">",
"      Woolfrey BF, Moody JA. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 1991; 4:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/5\">",
"      Weyant RS, Hollis DG, Weaver RE, et al. Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol 1995; 33:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/6\">",
"      Yih WK, Silva EA, Ida J, et al. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis 1999; 5:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/7\">",
"      Rodgers L, Martin SW, Cohn A, et al. Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011. Clin Infect Dis 2013; 56:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/8\">",
"      Warfel JM, Beren J, Merkel TJ. Airborne transmission of Bordetella pertussis. J Infect Dis 2012; 206:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/9\">",
"      Deen JL, Mink CA, Cherry JD, et al. Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995; 21:1211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/10\">",
"      Tiwari T, Murphy TV, Moran J, National Immunization Program, CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep 2005; 54:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/11\">",
"      Bergquist SO, Bernander S, Dahnsj&ouml; H, Sundel&ouml;f B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J 1987; 6:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/12\">",
"      Bass JW, Klenk EL, Kotheimer JB, et al. Antimicrobial treatment of pertussis. J Pediatr 1969; 75:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/13\">",
"      Centers for Disease Control and Prevention (CDC). Pertussis--United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002; 51:73.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. MMMWR. Notifiable Diseases and Mortality Tables. April 20, 2012. file://www.cdc.gov/mmwr/preview/mmwrhtml/mm6115md.htm?s_cid=mm6115md_w (Accessed on April 30, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/15\">",
"      Winter, K, Harriman, K, Schechter, R, et, al. Notes from the field: Pertussis--California, January-June 2010. MMWR Morb Mortal Wkly Rep 2010; 59:817.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Pertussis (Whooping Cough). Outbreaks. file://www.cdc.gov/pertussis/outbreaks.html.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/17\">",
"      Mink CM, Cherry JD, Christenson P, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992; 14:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/18\">",
"      Centers for Disease Control and Prevention (CDC). Pertussis epidemic--Washington, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/19\">",
"      Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005; 115:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/20\">",
"      Cherry JD. The present and future control of pertussis. Clin Infect Dis 2010; 51:663.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Pertussis (Whooping Cough). Pertussis in Other Countries. file://www.cdc.gov/pertussis/countries.html.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/22\">",
"      Centers for Disease Control and Prevention (CDC). Pertussis--United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2005; 54:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/23\">",
"      G&uuml;ri D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28:1230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/24\">",
"      Dworkin MS. Adults are whooping, but are internists listening? Ann Intern Med 2005; 142:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/25\">",
"      Hewlett EL, Edwards KM. Clinical practice. Pertussis--not just for kids. N Engl J Med 2005; 352:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/26\">",
"      Tanaka M, Vitek CR, Pascual FB, et al. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003; 290:2968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/27\">",
"      Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003; 22:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/28\">",
"      Cornia PB, Hersh AL, Lipsky BA, et al. Does this coughing adolescent or adult patient have pertussis? JAMA 2010; 304:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/29\">",
"      von K&ouml;nig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002; 2:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/30\">",
"      Nelson JD. The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. Am J Dis Child 1978; 132:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/31\">",
"      Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/32\">",
"      Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/33\">",
"      Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 2007; 26:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/34\">",
"      Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 2005; 24:S104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/35\">",
"      LAMBERT HJ. EPIDEMIOLOGY OF A SMALL PERTUSSIS OUTBREAK IN KENT COUNTY, MICHIGAN. Public Health Rep 1965; 80:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/36\">",
"      Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed) 1988; 296:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/37\">",
"      Liu BC, McIntyre P, Kaldor JM, et al. Pertussis in older adults: prospective study of risk factors and morbidity. Clin Infect Dis 2012; 55:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/38\">",
"      Paddock CD, Sanden GN, Cherry JD, et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 2008; 47:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/39\">",
"      Christie CD, Baltimore RS. Pertussis in neonates. Am J Dis Child 1989; 143:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/40\">",
"      Smith C, Vyas H. Early infantile pertussis; increasingly prevalent and potentially fatal. Eur J Pediatr 2000; 159:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/41\">",
"      Mills KH, Barnard A, Watkins J, Redhead K. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun 1993; 61:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/42\">",
"      Mills KH, Brady M, Ryan E, Mahon BP. A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity. Dev Biol Stand 1998; 95:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20918/abstract/43\">",
"      Mills KH, Ryan M, Ryan E, Mahon BP. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun 1998; 66:594.",
"     </a>",
"    </li>",
"    <li>",
"     Mattoo S, Cotter PA, Miller JF. Differential roles of Bordetella virulence factors as inducers and modulators of the host immune response. American Society for Microbiology; Proc 100th Gen Meet Am Soc Microbiol, Washington DC.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8043 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.131.41.98-0FBBA5EC0B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20918=[""].join("\n");
var outline_f20_27_20918=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H252275031\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H252274975\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H270844\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H252274996\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H252275003\">",
"      Transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H252275010\">",
"      Incidence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H252275017\">",
"      Evolving epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7117016\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H269764\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H252275031\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H252275812\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8043\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8043|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/48/29454\" title=\"figure 1\">",
"      Reported pertussis US 1922 to 2005",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/14/35053\" title=\"figure 2\">",
"      Incidence pertussis US 1990 to 2011",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8043|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/1/18\" title=\"table 1\">",
"      B pertussis virulence factors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16248?source=related_link\">",
"      Clinical features and diagnosis of Bordetella pertussis infection in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13911?source=related_link\">",
"      Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39271?source=related_link\">",
"      Treatment and prevention of Bordetella pertussis infection in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/14/25833?source=related_link\">",
"      Treatment and prevention of Bordetella pertussis infection in infants and children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_27_20919="Chlorothiazide: Pediatric drug information";
var content_f20_27_20919=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Chlorothiazide: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?35/2/35878?source=see_link\">",
"    see \"Chlorothiazide: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?20/62/21477?source=see_link\">",
"    see \"Chlorothiazide: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F149881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Diuril&reg;;",
"     </li>",
"     <li>",
"      Sodium Diuril&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F149882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Diuril&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1057259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihypertensive Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Diuretic, Thiazide",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11442237\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Edema, heart failure, bronchopulmonary dysplasia:",
"     </b>",
"     Limited data available;",
"     <b>",
"      Note:",
"     </b>",
"     The manufacturer states that I.V. and oral dosing are equivalent; however, some clinicians use lower I.V. doses due to poor oral absorption.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 20-40 mg/kg/day in 2 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 5-10 mg/kg/day in 2 divided doses (Costello, 2007); doses up to 20 mg/kg/day have been used",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hyperinsulinemia hypoglycemia, congenital hyperinsulinism (adjunct therapy):",
"     </b>",
"     Limited data available: Oral: 7-10 mg/kg/day in 2 divided doses in combination with diazoxide (Aynsley-Green, 2000; Hussain, 2004; Kapoor, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Diabetes insipidus (central):",
"     </b>",
"     Limited data available: Oral: 10 mg/kg/day in 2 divided doses; may need to titrate dose to target urine osmolality: 100-150 mOsm/L (Rivkees, 2008)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1057252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/2/35878?source=see_link\">",
"      see \"Chlorothiazide: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Infants, Children, and Adolescents:",
"     <b>",
"      Note:",
"     </b>",
"     The manufacturer states that I.V. and oral dosing are equivalent; however, some clinicians use lower I.V. doses due to the poor oral absorption.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Edema (diuresis), heart failure, hypertension:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Manufacturer labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants &lt;6 months: Oral: 10-30 mg/kg/day in divided doses once or twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants &ge;6 months, Children, and Adolescents: Oral: 10-20 mg/kg/day in divided doses once or twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Maximum daily doses:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:12em;text-align:justify;\">",
"     Infants and Children &lt;2 years: 375 mg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:12em;text-align:justify;\">",
"     Children 2-12 years: 1000 mg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:12em;text-align:justify;\">",
"     Adolescents: 2000 mg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Alternate dosing:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Oral: 10-40 mg/kg/day in 2 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Maximum daily doses:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:12em;text-align:justify;\">",
"     Infants and Children &lt;2 years: 375 mg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:12em;text-align:justify;\">",
"     Children &ge;2 years and Adolescents: 1000 mg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     I.V.: Limited data available: 5-10 mg/kg/day in divided doses once or twice daily (Costello, 2007); in some cases, doses up to 20 mg/kg/day have been used; maximum dose: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Diabetes insipidus (central):",
"     </b>",
"     Infants [breast milk-fed or formula (Similac PM 60/40)-fed]: Limited data available: Oral: 10 mg/kg/day in 2 divided doses; may need to titrate dose to target urine osmolality: 100-150 mOsm/L (Rivkees, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"     <b>",
"      Note:",
"     </b>",
"     The manufacturer states that I.V. and oral dosing are equivalent; however, some clinicians use lower I.V. doses due to the poor oral absorption.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hypertension:",
"     </b>",
"     Oral: 500-2000 mg/day divided in 1-2 doses (manufacturer labeling); doses of 125-500 mg/day have also been recommended (JNC 7)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Edema:",
"     </b>",
"     Oral, I.V.: 500-1000 mg once or twice daily; intermittent treatment (eg, therapy on alternative days) may be appropriate for some patients",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     ACC/AHA 2009 Heart Failure Guidelines:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Oral: 250-500 mg once or twice daily (maximum daily dose: 1000 mg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     I.V.: 500-1000 mg once or twice daily plus a loop diuretic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"     Infants, Children, Adolescents, and Adults: Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: Avoid use. Ineffective with Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute unless in combination with a loop diuretic (Aronoff, 2007).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     ACC/AHA 2005 Heart Failure guidelines suggest that thiazides lose their efficacy when Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;40 mL/minute.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F149853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution, as sodium [strength expressed as base]: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sodium Diuril&reg;: 0.5 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Diuril&reg;: 250 mg/5 mL (237 mL) [contains benzoic acid, ethanol 0.5%]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 250 mg, 500 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F149836\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes oral suspension",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1057263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Administer with food; administer early in day to avoid nocturia; if multiple daily dosing, the last dose should not be administered later than 6:00 pm unless instructed otherwise. Shake suspension well before use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: Reconstitute 500 mg vial with 18 mL SWI (resulting in 28 mg/mL concentration); may administer by direct I.V. infusion over 3-5 minutes or further dilute in D",
"     <sub>",
"      5",
"     </sub>",
"     W or NS and infuse over 30 minutes. Avoid extravasation of parenteral solution since it is extremely irritating to tissues; pH: 9.2-10. Do",
"     <b>",
"      not",
"     </b>",
"     administer via I.M. or Sub Q route.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F149918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     NS, LR,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Alprostadil.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1057255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Suspension: Store at 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F) in tightly closed container; protect from freezing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Tablets: Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F) in tightly closed container; protect from light and moisture",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Parenteral: Store intact vial at 2&deg;C to 25&deg;C (36&deg;F to 77&deg;F); reconstituted solution is stable for 24 hours at room temperature",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1057262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Suspension, tablets: Treatment of edema due to heart failure, hepatic cirrhosis,  and estrogen or corticosteroid therapy (FDA approved in infants, children, and adults); treatment of various forms of renal dysfunction, including nephrotic syndrome, acute glomerulonephritis, and chronic renal failure (FDA approved in infants, children, and adults); management of hypertension either alone or in combination with other antihypertensive agents (FDA approved in infants, children, and adults); has also been used for bronchopulmonary dysplasia (BPD) and central diabetes insipidus of infancy;",
"     <b>",
"      Note:",
"     </b>",
"     Use in pregnancy should be reserved for those cases causing extreme discomfort and unrelieved by rest; should not be routinely used during pregnancy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Parenteral: Treatment of edema due to heart failure, hepatic cirrhosis, and estrogen or corticosteroid therapy (FDA approved in adults); treatment of various forms of renal dysfunction including nephrotic syndrome, acute glomerulonephritis, and chronic renal failure (FDA approved in adults); has also been used for bronchopulmonary dysplasia (BPD);",
"     <b>",
"      Note:",
"     </b>",
"     Use in pregnancy should be reserved for those cases causing extreme discomfort and unrelieved by rest; should not be routinely used during pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F3196858\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Diuril [U.S., Canada] may be confused with Duorol brand name for acetaminophen [Spain]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F149917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Hypotension, orthostatic hypotension, necrotizing angiitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, fever, headache, restlessness, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Alopecia, erythema multiforme, exfoliative dermatitis, photosensitivity, purpura, rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Cholesterol increased, hypercalcemia, hyperglycemia, hyperuricemia, hypochloremic alkalosis, hypokalemia, hyponatremia, hypomagnesemia, triglycerides increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramping, anorexia, constipation, diarrhea, gastric irritation, nausea, pancreatitis, sialadenitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Impotence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, aplastic anemia, hemolytic anemia, leukopenia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Jaundice",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Muscle spasm, paresthesia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, xanthopsia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Glycosuria, hematuria (I.V.), interstitial nephritis, renal failure, renal dysfunction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Pneumonitis, pulmonary edema, respiratory distress",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylactic reactions, systemic lupus erythematosus",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1057267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to chlorothiazide or any component; cross-sensitivity with other thiazides or sulfonamides; anuria",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1057251\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with severe renal disease due to decreased efficacy; may precipitate azotemia. Use with caution in patients with severe hepatic dysfunction; in cirrhosis, avoid electrolyte and acid/base imbalances that might lead to hepatic encephalopathy. Use with caution in patients with prediabetes or diabetes mellitus; may alter glucose control. Use with caution in patients with a history of gout; may cause hyperuricemia and in certain patients with a history of gout, a familial predisposition to gout, or chronic renal failure, gout can be precipitated. Use with caution in patients with moderate or high cholesterol concentrations.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Use with caution in patients with hypercalcemia or parathyroid disease; thiazide diuretics may decrease renal calcium excretion; pathologic changes in the parathyroid glands with hypercalcemia and hypophosphatemia have been observed with prolonged use.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1057250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity reactions may occur with chlorothiazide; risk is increased in patients with a history of allergy or bronchial asthma. Chemical similarities are present among sulfonamides, sulfonylureas, carbonic anhydrase inhibitors, thiazides, and loop diuretics (except ethacrynic acid). Use in patients with sulfonamide allergy is specifically contraindicated in product labeling; however, a risk of cross-reaction exists in patients with allergy to any of these compounds; avoid use when previous reaction has been severe. Discontinue if signs of hypersensitivity are noted.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     May cause hypokalemia; increased risk associated with aggressive diuresis, severe cirrhosis, or after prolonged therapy; alterations in adequate oral potassium intake may also increase risk; monitor serum potassium concentrations at baseline and periodically; correct hypokalemia prior to initiating therapy. Other electrolyte disorders may occur, including hyponatremia, hypomagnesemia, and hypochloremic metabolic alkalosis; monitor electrolytes. May cause SLE exacerbation or activation. Photosensitization may occur; patients should be counseled.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Oral suspension contains benzoic acid; benzoic acid is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse; use the oral suspension containing benzyl alcohol with caution in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate, a metabolite of benzyl alcohol, displaces bilirubin from protein binding sites.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299022\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F149845\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Thiazide Diuretics may enhance the hypotensive effect of ACE Inhibitors. Specifically, postural hypotension which can accompany ACE Inhibitor initiation. Thiazide Diuretics may enhance the nephrotoxic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): May enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfuzosin: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Allopurinol: Thiazide Diuretics may enhance the potential for allergic or hypersensitivity reactions to Allopurinol. Thiazide Diuretics may increase the serum concentration of Allopurinol. Specifically, Thiazide Diuretics may increase the concentration of Oxypurinol, an active metabolite of Allopurinol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amifostine: Antihypertensives may enhance the hypotensive effect of Amifostine.  Management: When amifostine is used at chemotherapy doses, antihypertensive medications should be withheld for 24 hours prior to amifostine administration. If antihypertensive therapy can not be withheld, amifostine should not be administered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Analgesics (Opioid): May enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidiabetic Agents: Thiazide Diuretics may diminish the therapeutic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensives: May enhance the hypotensive effect of other Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta2-Agonists: May enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the absorption of Thiazide Diuretics. The diuretic response is likewise decreased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts: Thiazide Diuretics may decrease the excretion of Calcium Salts. Continued concomitant use can also result in metabolic alkalosis.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: Thiazide Diuretics may enhance the adverse/toxic effect of CarBAMazepine. Specifically, there may be an increased risk for hyponatremia.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Orally Inhaled): May enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dofetilide: Thiazide Diuretics may enhance the QTc-prolonging effect of Dofetilide. Thiazide Diuretics may increase the serum concentration of Dofetilide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypertensive Properties): May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypotensive Properties): May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Licorice: May enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Thiazide Diuretics may decrease the excretion of Lithium.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): Thiazide Diuretics may enhance the hypercalcemic effect of Multivitamins/Minerals (with ADEK, Folate, Iron).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May diminish the therapeutic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OXcarbazepine: Thiazide Diuretics may enhance the adverse/toxic effect of OXcarbazepine. Specifically, there may be an increased risk for hyponatremia.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphodiesterase 5 Inhibitors: May enhance the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RiTUXimab: Antihypertensives may enhance the hypotensive effect of RiTUXimab.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Phosphates: Diuretics may enhance the nephrotoxic effect of Sodium Phosphates. Specifically, the risk of acute phosphate nephropathy may be enhanced.  Management: Consider avoiding this combination by temporarily suspending treatment with diuretics, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, hydrate adequately and monitor fluid and renal status.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: Thiazide Diuretics may enhance the hypokalemic effect of Topiramate. Thiazide Diuretics may increase the serum concentration of Topiramate.  Management: Monitor for increased topiramate levels/adverse effects (e.g., hypokalemia) with initiation/dose increase of a thiazide diuretic. Closely monitor serum potassium concentrations with concomitant therapy. Topiramate dose reductions may be necessary.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Toremifene: Thiazide Diuretics may enhance the hypercalcemic effect of Toremifene.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin D Analogs: Thiazide Diuretics may enhance the hypercalcemic effect of Vitamin D Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1057269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid natural licorice (causes sodium and water retention and increases potassium loss)",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F149848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F149863\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies; however, studies were not complete. Chlorothiazide crosses the placenta and is found in cord blood. Maternal use may cause may cause fetal or neonatal jaundice, thrombocytopenia, or other adverse events observed in adults. Use of thiazide diuretics during normal pregnancies is not appropriate; use may be considered when edema is due to pathologic causes (as in the nonpregnant patient); monitor.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1057258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum electrolytes, BUN, creatinine, blood pressure, fluid balance, body weight",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1057249\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits sodium reabsorption in the distal tubules causing increased excretion of sodium, chloride, potassium, bicarbonate, magnesium, phosphate, calcium (transiently) and water",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1057265\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Diuresis: Oral: Within 2 hours; I.V.: Within 15 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect: Diuresis: Oral: 4 hours; I.V.: 30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Diuresis: Oral: ~6-12 hours; I.V.: 2 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1057266\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Poor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 9% to 56%; dose-dependent",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 45-120 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Oral: Within 4 hours; I.V.: 30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urine (Oral: 10% to 15% excreted unchanged; I.V.: 96% excreted unchanged)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1057257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?20/62/21477?source=see_link\">",
"      see \"Chlorothiazide: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May cause photosensitivity reactions (eg, exposure to sunlight may cause severe sunburn, skin rash, redness, or itching); avoid exposure to sunlight and artificial light sources (sunlamps, tanning booth/bed); wear protective clothing, wide-brimmed hats, sunglasses, and lip sunscreen (SPF &ge;15); use a sunscreen [broad-spectrum sunscreen or physical sunscreen (preferred) or sunblock with SPF &ge;15]; contact physician if reaction occurs. Take with meals early in the day to avoid nocturia. A potassium supplement may be prescribed or dietary changes recommended; do not change diet while taking this medication unless recommended by prescriber, especially with concurrent use of potassium supplements or medications to reduce potassium loss. May cause dizziness or postural hypotension. Report palpitations, muscle cramping, or skin rash.",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F11338404\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A 50 mg/mL oral suspension may be made with tablets. Crush ten 500 mg chlorothiazide tablets in a mortar and reduce to a fine powder; mix with a small amount of glycerin to form a uniform paste. Add 2 g carboxymethylcellulose gel (mix 2 g carboxymethylcellulose with 5-10 mL water to form a paste; add 40 mL water and heat to 60&deg;C with moderate stirring until dissolution occurs; cool and allow to stand for 1-2 hours to form a clear gel). Dissolve 500 mg citric acid in 5 mL water and add to chlorothiazide carboxymethylcellulose mixture with 0.1% parabens. Add a quantity of purified water sufficient to make 100 mL (Nahata, 2004). Label \"shake well\" and \"refrigerate\". Stable for 30 days.",
"    </p>",
"    <div class=\"reference\">",
"     Nahata MC, Pai VB, and Hipple TF,",
"     <i>",
"      Pediatric Drug Formulations",
"     </i>",
"     , 5th ed, Cincinnati, OH: Harvey Whitney Books Co, 2004.",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed. Philadelphia, PA: American College of Physicians, 2007.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Aynsley-Green A, Hussain K, Hall J, et al, \"Practical Management of Hyperinsulinism in Infancy,\"",
"      <i>",
"       Arch Dis Child Fetal Neonatal Ed",
"      </i>",
"      , 2000, 82(2):F98-107.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?20/27/20919/abstract-text/10685981/pubmed\" id=\"10685981\" target=\"_blank\">",
"        10685981",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chobanian AV, Bakris GL, Black HR, et al, &ldquo;The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2003, 289(19):2560-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?20/27/20919/abstract-text/12748199 /pubmed\" id=\"12748199 \" target=\"_blank\">",
"        12748199",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Costello JM and Almodovar MC, \"Emergency Care for Infants and Children With Acute Cardiac Disease,\"",
"      <i>",
"       Clin Pediatr Emerg Med",
"      </i>",
"      , 2007, 8:145-55.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hunt SA, Abraham WT, Chin MH, et al, \"ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2005, 112(12):e154-235.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?20/27/20919/abstract-text/16160202/pubmed\" id=\"16160202\" target=\"_blank\">",
"        16160202",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hussain K and Aynsley-Green A, \"Hyperinsulinaemic Hypoglycaemia in Preterm Neonates,\"",
"      <i>",
"       Arch Dis Child Fetal Neonatal Ed",
"      </i>",
"      , 2004, 89(1):F65-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?20/27/20919/abstract-text/14711860/pubmed\" id=\"14711860\" target=\"_blank\">",
"        14711860",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kapoor RR, Flanagan SE, James C, et al, \"Hyperinsulinaemic Hypoglycaemia,\"",
"      <i>",
"       Arch Dis Child",
"      </i>",
"      , 2009, 94(6):450-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?20/27/20919/abstract-text/19193661/pubmed\" id=\"19193661\" target=\"_blank\">",
"        19193661",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rivkees SA, \"The Management of Central Diabetes Insipidus in Infancy,\"",
"      <i>",
"       US Pediatrics",
"      </i>",
"      , 2008, 66-8.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13148 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-6DAE62D42F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20919=[""].join("\n");
var outline_f20_27_20919=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149881\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149882\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057259\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11442237\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057252\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149853\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149836\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057263\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149918\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057255\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057262\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3196858\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149917\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057267\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057251\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057250\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299022\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149845\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057269\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149848\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149863\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057258\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057249\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057265\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057266\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057257\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11338404\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13148\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13148|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/2/35878?source=related_link\">",
"      Chlorothiazide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?20/62/21477?source=related_link\">",
"      Chlorothiazide: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_27_20920="Approach to vaginal bleeding in the emergency department";
var content_f20_27_20920=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to vaginal bleeding in the emergency department",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20920/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20920/contributors\">",
"     Robert Dart, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20920/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20920/contributors\">",
"     Robert S Hockberger, MD, FACEP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20920/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20920/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/27/20920/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of patients presenting to the emergency department (ED) with vaginal bleeding depends upon a number of factors including patient age, pregnancy status, chronicity and severity of bleeding, comorbidities, and medications. An understanding of the menstrual cycle and an organized approach to patient evaluation enable the ED clinician to form an appropriate differential diagnosis and treatment plan.",
"   </p>",
"   <p>",
"    This topic review will discuss the basic physiology of menstruation and provide a basic approach to the adult patient who presents to the ED with vaginal bleeding. Detailed discussions of pediatric patients with vaginal bleeding and of specific causes of genital tract bleeding are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/23/19834?source=see_link\">",
"     \"Spontaneous abortion: Risk factors, etiology, clinical manifestations, and diagnostic evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29417?source=see_link\">",
"     \"Placental abruption: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/18/35113?source=see_link\">",
"     \"Overview of causes of genital tract bleeding in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=see_link\">",
"     \"Evaluation and management of lower genital tract trauma in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/25/20887?source=see_link\">",
"     \"Initial approach to the premenopausal woman with abnormal uterine bleeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The average age of menarche is approximately 12.5 years. The regularity of the menstrual cycle and ovulation are dependent on a complex hormonal feedback mechanism involving the hypothalamus, the pituitary, and the ovary (",
"    <a class=\"graphic graphic_figure graphicRef72415 \" href=\"UTD.htm?34/26/35246\">",
"     figure 1",
"    </a>",
"    ). A basic summary of menstruation follows. A more detailed description of menstruation is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27685?source=see_link\">",
"     \"Physiology of the normal menstrual cycle\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=see_link\">",
"     \"Normal puberty\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the follicular phase of the menstrual cycle, gonadotropin-releasing hormone (GRH) is secreted by the hypothalamus which then stimulates the pituitary to release both luteinizing hormone (LH) and follicle stimulating hormone (FSH). In the ovary, under the influence of these two hormones, two things occur: a dominant follicle matures and increasing levels of estrogen are secreted. Once estrogen levels reach a threshold level for about 36 hours, a surge in LH occurs, which triggers ovulation and the beginning of the",
"    <strong>",
"     luteal phase",
"    </strong>",
"    of the menstrual cycle. Under the influence of LH, the ruptured dominant follicle rapidly evolves into the corpus luteum, which secretes increased amounts of progesterone. If pregnancy does not occur, the corpus luteum involutes 14 days after ovulation, progesterone levels fall, and menstruation occurs.",
"   </p>",
"   <p>",
"    The endometrium is composed of three layers: basal, spongy, and compact. The basal layer contains stem cells for regeneration but also provides a cleavage plane between the basal and spongy layers when menstruation occurs. The endometrium undergoes characteristic changes in structure and thickness during the course of each menstrual cycle.",
"   </p>",
"   <p>",
"    The proliferative phase of endometrial maturation occurs primarily under the influence of estrogen and occurs during the follicular phase of the menstrual cycle. During the proliferative phase, the endometrial glands and stroma grow and proliferate, causing the endometrium to thicken.",
"   </p>",
"   <p>",
"    The secretory phase of endometrial maturation occurs in the luteal phase of the menstrual cycle, primarily under the influence of progesterone. During the secretory phase, endometrial glands mature and develop secretory vacuoles.",
"   </p>",
"   <p>",
"    The drop in progesterone during the latter part of the luteal phase triggers release of prostaglandins which cause vasospasm of the arteries feeding the spongy and compact layers of the endometrium. This leads to a sloughing of the outer layers of the endometrium (ie, menstruation).",
"   </p>",
"   <p>",
"    The duration of a normal menstrual period averages about four days (range one to eight days) with typical blood loss of approximately 50 cc (range 20 to 80 cc) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ask the patient about the volume and duration of bleeding (",
"    <a class=\"graphic graphic_table graphicRef69390 \" href=\"UTD.htm?14/2/14379\">",
"     table 1",
"    </a>",
"    ). Useful information includes the number of tampons or pads changed over the last 12 to 24 hours, whether these were saturated, and the presence or absence of clots. Women with heavy bleeding typically need to change",
"    <span class=\"nowrap\">",
"     pads/tampons",
"    </span>",
"    a minimum of once every three hours. Clots with a diameter greater than 1 cm are associated with menstrual blood loss of at least 80 cc [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/2\">",
"     2",
"    </a>",
"    ]. Ask whether the bleeding started at the scheduled onset of a menstrual period, or whether bleeding began prematurely or late. Ask if the patient has missed a menstrual period. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/24/23944?source=see_link\">",
"     \"Terminology and evaluation of abnormal uterine bleeding in premenopausal women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ask about the possibility of pregnancy. Does the patient have unprotected sexual intercourse? In the premenopausal patient, a menstrual history is obtained including: the date of the last period, any change in the frequency of periods, whether flow is typically heavy or prolonged, and whether the patient has had similar episodes of bleeding. A gynecological and obstetrical history includes: the outcome of all prior pregnancies (including miscarriages and procedures for pregnancy termination), pregnancy complications, current or recent methods of contraception, and any pelvic infections.",
"   </p>",
"   <p>",
"    Ask about systemic disease and obtain a complete list of the patient's current medications. Ask whether the patient takes hormone replacement therapy or receives treatments to assist with in vitro fertilization.",
"   </p>",
"   <p>",
"    Ask about associated symptoms. Fever and chills suggest an infectious etiology such as pelvic inflammatory disease or a urinary tract infection (UTI). When urinary symptoms are present, bleeding may be from hemorrhagic cystitis rather than a gynecologic problem. Any pain should be characterized, including: onset, provocative or palliative elements, quality, radiation, site, and time course. Midline crampy abdominal pain often originates from the uterus, but may be related to bladder pathology. Low, lateral abdominal pain associated with vaginal bleeding suggests pathology in the fallopian tube or ovary.",
"   </p>",
"   <p>",
"    A history of bleeding from multiple sites including mucous membranes, easy bruisability, prolonged heavy periods, or a family history of a bleeding disorder suggests a coagulation disorder. Coagulopathy should be suspected in a woman with menorrhagia since menarche. Hemostatic abnormalities in women with menorrhagia are common and may include abnormal platelet aggregation, Von Willebrand disease, and single clotting factor deficiencies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/25/20887?source=see_link&amp;anchor=H5#H5\">",
"     \"Initial approach to the premenopausal woman with abnormal uterine bleeding\", section on 'When does the bleeding occur?'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=see_link\">",
"     \"Approach to the adult patient with a bleeding diathesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24794?source=see_link\">",
"     \"Clinical presentation and diagnosis of von Willebrand disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other, apparently unrelated, symptoms may suggest a diagnosis. The presence of weight gain, chronic fatigue, cold intolerance, constipation, alopecia, or skin changes suggests hypothyroidism. Obesity, hirsutism, and irregular periods are suggestive of polycystic ovary syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/3\">",
"     3",
"    </a>",
"    ]. Headache accompanied by visual changes is suggestive of a pituitary tumor. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=see_link\">",
"     \"Clinical manifestations of hypothyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=see_link\">",
"     \"Clinical manifestations of polycystic ovary syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/18/29992?source=see_link\">",
"     \"Causes, presentation, and evaluation of sellar masses\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patient age alters the differential diagnosis. The risk of endometrial carcinoma increases substantially in any woman over the age of 35 with excessive genital tract bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/4\">",
"     4",
"    </a>",
"    ]. Bleeding in a child under the age of nine is uncommon and warrants evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/27/18874?source=see_link\">",
"     \"Endometrial carcinoma: Epidemiology and risk factors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/29/26072?source=see_link\">",
"     \"Vulvovaginal complaints in the prepubertal child\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recent significant weight gain or loss, an eating disorder, or major stress may disturb hormonal regulation of the menstrual cycle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination is directed at uncovering evidence of significant blood loss and identifying the underlying etiology of genital tract bleeding. Vital signs are reviewed to assess for hemodynamic instability. Pale skin or conjunctiva suggests anemia. Mucosal hemorrhage, purpura, or petechiae suggests a bleeding disorder.",
"   </p>",
"   <p>",
"    General appearance may suggest a diagnosis. Obesity along with hirsutism suggests polycystic ovarian syndrome. Virilization or a cushingoid appearance suggests a hormonally active tumor.",
"   </p>",
"   <p>",
"    The abdominal exam focuses on the presence of an abdominal mass, localized abdominal tenderness, or peritoneal signs. Peritoneal signs may be present with pelvic inflammatory disease (PID), a hemorrhagic ovarian cyst, or a ruptured ectopic pregnancy.",
"   </p>",
"   <p>",
"    The pelvic exam is useful in determining the volume and the site of bleeding, the presence of a foreign body or traumatic injury, the presence of products of conception, and the presence of vaginal discharge. Uterine size and surface contour, adnexal mass or tenderness, and the presence of cervical motion tenderness are assessed.",
"   </p>",
"   <p>",
"    The pelvic examination is",
"    <strong>",
"     not",
"    </strong>",
"    performed on women in their third trimester of pregnancy with vaginal bleeding because of the risk of causing separation of a placenta previa. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35032?source=see_link\">",
"     \"Clinical features, diagnosis, and course of placenta previa\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with symptoms suggestive of a pituitary tumor are examined for visual field deficits and nipple discharge. Peripheral edema, hair loss, and decreased reflexes may be associated with hypothyroidism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ANCILLARY STUDIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pregnancy tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;A qualitative urine pregnancy test (hCG) should be obtained in any woman of childbearing age with vaginal bleeding whose pregnancy status is in doubt. A quantitative serum hCG level should be obtained when the urine test is positive and in the presence of a negative urine test when the clinical suspicion for pregnancy is high [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/6\">",
"     6",
"    </a>",
"    ]. Both ectopic pregnancy and nonviable intrauterine pregnancy are associated with lower levels of hCG than expected from the estimated gestational age of the fetus. Symptomatic patients with hCG levels below 1000",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    are four times more likely to have an ectopic pregnancy than those with higher levels [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pelvic ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;A positive pregnancy test in a patient with vaginal bleeding is followed by a transvaginal ultrasound examination. Transvaginal ultrasound can accurately determine the presence or absence of an intrauterine pregnancy as early as approximately 35 days gestation, or above an hCG level of 1500",
"    <span class=\"nowrap\">",
"     IU/L.",
"    </span>",
"    In patients with third-trimester bleeding, transvaginal ultrasound is very sensitive in identifying placenta previa, but less sensitive in identifying placental abruption [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/24/34184?source=see_link\">",
"     \"Ultrasonography of pregnancy of unknown location\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/23/19834?source=see_link\">",
"     \"Spontaneous abortion: Risk factors, etiology, clinical manifestations, and diagnostic evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pelvic ultrasound is less helpful in the initial evaluation of nonpregnant patients with painless vaginal bleeding, but may help to identify some causes of vaginal bleeding associated with lower abdominal pain, such as ruptured ovarian cyst and ovarian torsion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/40/9863?source=see_link\">",
"     \"Evaluation and management of ruptured ovarian cyst\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23690?source=see_link\">",
"     \"Ovarian and fallopian tube torsion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Additional tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other studies are obtained based on clinical circumstances. Obtain a blood type and crossmatch blood sample for any woman with severe or symptomatic vaginal bleeding who may require transfusion; for less severe but concerning hemorrhage, a blood type and screen is generally sufficient. A hematocrit is obtained if significant bleeding may have occurred. If a coagulopathy is suspected, a platelet count and prothrombin time with international normalized ratio (INR) is obtained. Vaginal cultures are obtained if infection is a concern.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many causes of genital tract bleeding exist. Below is a select list of causes important to the emergency clinician. More detailed discussions of the differential diagnosis are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/18/35113?source=see_link\">",
"     \"Overview of causes of genital tract bleeding in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Life-threatening causes of genital tract bleeding in early pregnancy include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ruptured ectopic pregnancy &ndash; Clinical manifestations typically appear six to eight weeks after the last normal menstrual period, but can occur later. Normal pregnancy discomforts (eg, breast tenderness, frequent urination, nausea) are often present, in addition to the classic symptoms of abdominal pain, amenorrhea, and vaginal bleeding. Exam findings can range from unremarkable to profound shock. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/24/34184?source=see_link\">",
"       \"Ultrasonography of pregnancy of unknown location\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Life-threatening causes of genital tract bleeding in late pregnancy and the peripartum period include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Placental abruption &ndash; The classic symptoms and signs include vaginal bleeding (&gt;80 percent of patients), abdominal pain (&gt;50 percent), uterine contractions, and uterine tenderness. The amount of vaginal bleeding does not correlate well with the extent of maternal hemorrhage and cannot be used to gauge the severity of abruption. Ultrasound is not sensitive for detecting abruption. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29417?source=see_link\">",
"       \"Placental abruption: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Placenta previa &ndash; Most patients present with painless vaginal bleeding, many have uterine contractions as well, but a few are asymptomatic until labor begins. Ultrasound is a useful tool for diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35032?source=see_link\">",
"       \"Clinical features, diagnosis, and course of placenta previa\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Postpartum hemorrhage (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/38/42600?source=see_link\">",
"       \"Overview of postpartum hemorrhage\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other life-threatening causes of genital tract bleeding can include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute severe menorrhagia &ndash; Treatment of this condition includes high dose intravenous estrogen. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20122?source=see_link\">",
"       \"Chronic menorrhagia or anovulatory uterine bleeding\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Genital trauma (including sexual and physical abuse) &ndash; Rates of domestic abuse increase during pregnancy, and abuse remains an important cause of maternal morbidity and mortality. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=see_link\">",
"       \"Evaluation and management of lower genital tract trauma in women\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other important causes of genital tract bleeding include (",
"    <a class=\"graphic graphic_table graphicRef74527 \" href=\"UTD.htm?25/45/26334\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Spontaneous abortion &ndash; Women who are actively in the process of having a spontaneous abortion usually present with a history of amenorrhea, vaginal bleeding, and pelvic pain. On examination, the cervix is open and the products of conception can be visualized in the vagina or cervical os, if they have not already been passed. Ultrasound is the cornerstone of diagnosis and ruling out ectopic pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/23/19834?source=see_link\">",
"       \"Spontaneous abortion: Risk factors, etiology, clinical manifestations, and diagnostic evaluation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ruptured ovarian cyst &ndash; Rupture is characterized by the sudden onset of unilateral, lower abdominal pain. The onset of pain often occurs during strenuous activities, such as exercise or sexual intercourse. Light vaginal bleeding may also occur. Ectopic pregnancy must be ruled out. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/40/9863?source=see_link\">",
"       \"Evaluation and management of ruptured ovarian cyst\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ovarian torsion &ndash; The diagnosis should be considered in women with lower abdominal pain, an ovarian",
"      <span class=\"nowrap\">",
"       cyst/mass,",
"      </span>",
"      and diminished or absent blood flow in the ovarian vessels (determined by ultrasound), after exclusion of ectopic pregnancy, pelvic inflammatory disease, and appendicitis. The presence of local hemorrhage further suggests the diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23690?source=see_link\">",
"       \"Ovarian and fallopian tube torsion\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Gynecologic infections (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=see_link\">",
"       \"Approach to women with symptoms of vaginitis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Foreign bodies (eg, tampon, intrauterine device).",
"     </li>",
"     <li>",
"      Drugs (eg, hormones, anticoagulants, chemotherapeutic agents, steroids).",
"     </li>",
"     <li>",
"      Coagulation disorders (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=see_link\">",
"       \"Approach to the adult patient with a bleeding diathesis\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Gynecologic cancers (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/27/18874?source=see_link\">",
"       \"Endometrial carcinoma: Epidemiology and risk factors\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Common causes of genital tract bleeding in premenopausal women include (",
"    <a class=\"graphic graphic_table graphicRef61684 \" href=\"UTD.htm?30/12/30924\">",
"     table 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dysfunctional uterine bleeding (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20122?source=see_link\">",
"       \"Chronic menorrhagia or anovulatory uterine bleeding\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Uterine leiomyoma (fibroid) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=see_link\">",
"       \"Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Uterine polyps (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/10/7336?source=see_link\">",
"       \"Endometrial polyps\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Infection (eg, pelvic inflammatory disease) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Endocrine dysfunction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Common causes of genital tract bleeding in postmenopausal women include (",
"    <a class=\"graphic graphic_table graphicRef61684 \" href=\"UTD.htm?30/12/30924\">",
"     table 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cancer (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/27/18874?source=see_link\">",
"       \"Endometrial carcinoma: Epidemiology and risk factors\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Diseases sometimes mistaken for genital tract bleeding include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Urinary tract disease: infection, cancer.",
"     </li>",
"     <li>",
"      Lower gastrointestinal bleeding: hemorrhoids, inflammatory bowel disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC APPROACH AND DISPOSITION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Basic questions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient with vaginal bleeding is approached systematically based on the answers to a few simple questions (",
"    <a class=\"graphic graphic_algorithm graphicRef77923 \" href=\"UTD.htm?43/38/44640\">",
"     algorithm 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Is the patient hemodynamically unstable?",
"     </li>",
"     <li>",
"      Is the patient pregnant? If yes, is it the first trimester, or later in the pregnancy?",
"     </li>",
"     <li>",
"      If not pregnant, what are the most important diagnoses to consider in this patient's age group?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Determine hemodynamic status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemodynamically unstable patients are resuscitated in standard fashion, including: airway assessment, placement of two large bore (14 gauge or larger) peripheral intravenous lines (IVs), and type and cross-matching of blood in preparation for transfusion. Determine pregnancy status immediately. Pregnant patients with hemodynamic instability from blood loss (eg, ruptured ectopic pregnancy) require immediate obstetrical consultation and often require surgery or delivery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=see_link&amp;anchor=H30#H30\">",
"     \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hemodynamic instability in a nonpregnant patient with significant blood loss is treated initially with IV boluses of crystalloid, and possibly infusion of packed red blood cells. The clinician then determines whether blood loss is ongoing. This is done by estimating the volume of blood loss in the previous 24 hours, and the volume of blood present on pelvic exam (",
"    <a class=\"graphic graphic_table graphicRef69390 \" href=\"UTD.htm?14/2/14379\">",
"     table 1",
"    </a>",
"    ). Emergent gynecologic consultation is necessary. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'History'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    If immediate gynecologic consultation is unavailable, placement of a Foley catheter with a 30 mL balloon into the uterine cavity transcervically and inflation of the balloon may provide tamponade in hemodynamically unstable women with acute, profuse uterine bleeding, until definitive management can be instituted. This procedure is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/2/11305?source=see_link&amp;anchor=H17#H17\">",
"     \"Managing an episode of severe or prolonged uterine bleeding\", section on 'Intrauterine tamponade'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Determine pregnancy status",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in evaluating premenopausal patients with vaginal bleeding is to determine pregnancy status using a human chorionic gonadotropin (hCG) assay. In patients with early pregnancy, a pelvic ultrasound is obtained to determine the pregnancy location (intrauterine versus ectopic) and viability. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/24/34184?source=see_link\">",
"     \"Ultrasonography of pregnancy of unknown location\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with a nonviable intrauterine pregnancy, the decision to intervene surgically is based on the patient's hemodynamic status, degree of anemia, severity of active bleeding, the content of the endometrial cavity, and patient preference [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/9\">",
"     9",
"    </a>",
"    ]. Gynecologic consultation is necessary. Many patients with early spontaneous miscarriage can be safely discharged. Patients found to have a viable IUP can be followed on an outpatient basis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15465?source=see_link\">",
"     \"Overview of the etiology and evaluation of vaginal bleeding in pregnant women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/49/2841?source=see_link\">",
"     \"Spontaneous abortion: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A ruptured ectopic pregnancy is managed surgically and requires immediate gynecological consultation. Assume such patients are in imminent danger of hemorrhagic shock, if not already in shock. Nonsurgical management is an option in a subset of patients with an unruptured ectopic pregnancy. This decision is made in consultation with a gynecologist, after considering patient preference and reliability, ultrasound findings, and the quantitative hCG value [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If after the ED evaluation the condition of the pregnancy remains uncertain (eg, hCG level is below 1000 and ultrasound findings are unclear) and there is no hemodynamic instability, the patient can be discharged but requires outpatient follow-up with a gynecologist, typically within 48 hours, for a repeat evaluation and hCG test [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients with vaginal bleeding in late pregnancy, placenta previa, placental abruption, and trauma (including physical abuse) are major concerns. Placenta previa is generally painless; abruptio placenta is usually associated with pain. Pelvic examination is",
"    <strong>",
"     not",
"    </strong>",
"    performed on women in their third trimester of pregnancy with vaginal bleeding because of the risk of causing separation of a placenta previa. Immediate obstetrical consultation is required. Assume the patient is in imminent danger of hemorrhagic shock, if not already in shock. Ultrasound is",
"    <strong>",
"     not",
"    </strong>",
"    sufficiently sensitive to diagnose placental abruption, but in experienced hands is the modality of choice to diagnose placenta previa. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Determine hemodynamic status'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=see_link\">",
"     \"Evaluation and management of lower genital tract trauma in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35032?source=see_link\">",
"     \"Clinical features, diagnosis, and course of placenta previa\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29417?source=see_link\">",
"     \"Placental abruption: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pregnant patients with vaginal bleeding who are Rh negative generally need treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/58/11175?source=see_link\">",
"     Rho(D) immune globulin",
"    </a>",
"    (Rhogam) to prevent Rh(D) alloimmunization. We recommend administration of antenatal anti-D immune globulin when there is an increased risk of fetomaternal hemorrhage. Examples of such cases include miscarriage, ectopic pregnancy, blunt abdominal trauma, antepartum bleeding, and fetal death. We administer 300 micrograms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40648?source=see_link\">",
"     \"Prevention of Rh(D) alloimmunization\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Determine differential diagnosis based on age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonpregnant patients can be subdivided into three groups: premenarchal, premenopausal, and peri or postmenopausal. A bimanual and speculum exam is generally performed as part of the evaluation of vaginal bleeding in the nonpregnant patient. These examinations enable the clinician to determine the presence and extent of cervical bleeding and to detect several important causes of bleeding including vaginal trauma, masses, and foreign bodies. The discussion below focuses on diagnoses requiring emergent or urgent intervention, and common diagnoses encountered in the emergency department. Alternative diagnoses are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/18/35113?source=see_link\">",
"     \"Overview of causes of genital tract bleeding in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Premenarchal patient &ndash; The differential diagnosis of vaginal bleeding in the premenarchal patient includes vulvovaginitis, trauma, foreign body, urethral prolapse, sexual abuse, and a hormonally active tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/5\">",
"       5",
"      </a>",
"      ]. Treatment is directed at the underlying cause. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/29/26072?source=see_link\">",
"       \"Vulvovaginal complaints in the prepubertal child\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Premenopausal patient &ndash; Important and common causes of vaginal bleeding to consider in the nonpregnant premenopausal patient include ruptured ovarian cyst, ovarian torsion, dysfunctional uterine bleeding, uterine leiomyoma (ie, fibroid), uterine polyps, and pelvic inflammatory disease (PID). Patients with a ruptured ovarian cyst, ovarian torsion, or PID present primarily with lower abdominal pain; vaginal bleeding is generally incidental. Vaginal discharge is neither sensitive nor specific for PID. Significant internal bleeding or any suspicion for torsion requires emergent gynecological consultation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/40/9863?source=see_link\">",
"       \"Evaluation and management of ruptured ovarian cyst\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23690?source=see_link\">",
"       \"Ovarian and fallopian tube torsion\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Painless vaginal bleeding in premenopausal women is most often caused by dysfunctional uterine bleeding (DUB), which is defined as abnormal bleeding from the uterine endometrium that is unrelated to anatomic lesions of the uterus. Eighty percent of episodes are secondary to failure to ovulate. The remaining 20 percent of episodes are secondary to either dysfunction of the corpus luteum or an atrophic endometrium [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/12\">",
"       12",
"      </a>",
"      ]. If bleeding is sufficiently severe to require acute treatment, it can be managed with intravenous or oral estrogen. Disposition depends upon the severity of bleeding and the response to treatment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20122?source=see_link\">",
"       \"Chronic menorrhagia or anovulatory uterine bleeding\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/2/11305?source=see_link\">",
"       \"Managing an episode of severe or prolonged uterine bleeding\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Of note, endometrial cancer can present as vaginal bleeding in patients as young as 35, and caution should be used in prescribing oral contraceptives to patients with suspected DUB who have predisposing risk factors for endometrial cancer (eg, family history of cancer, obesity, chronic estrogen therapy). Such patients should be referred to a gynecologist for evaluation before the initiation of such therapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/27/18874?source=see_link\">",
"       \"Endometrial carcinoma: Epidemiology and risk factors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Peri and postmenopausal patient &ndash; The primary diagnosis of concern in the nonpregnant patient over 35 is endometrial cancer. These patients should not be started on oral contraceptives and require close follow-up with a gynecologist who can direct the diagnostic evaluation. Ultrasound or hysteroscopy with endometrial biopsy may be needed. Of patients undergoing hysteroscopy for evaluation of vaginal bleeding, 4 percent of premenopausal and 11 percent of postmenopausal women are ultimately diagnosed with endometrial cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20920/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/27/18874?source=see_link\">",
"       \"Endometrial carcinoma: Epidemiology and risk factors\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Other important issues to consider in the older patient with vaginal bleeding include anticoagulant medications, hormonal medications, and underlying coagulopathy.",
"      <br/>",
"      <br/>",
"      In the hemodynamically stable patient the need for blood transfusion is based upon the hemoglobin level as well as the presence of comorbidities that affect the ability to tolerate anemia, such as coronary heart disease. At a minimum, all patients with significant anemia should be started on iron supplementation. While most patients with vaginal bleeding can be managed as outpatients, disposition depends upon hemodynamic status, the severity of ongoing blood loss, the degree of anemia, and the presence of major comorbidities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24398144\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The management of patients presenting to the emergency department with vaginal bleeding depends upon a number of factors including patient age and pregnancy status. A basic understanding of the physiology of menstruation and a systematic approach are important for diagnosis and management. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Physiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Life-threatening causes of vaginal bleeding include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Pregnancy-related: ectopic pregnancy, placental abruption, placenta previa, postpartum hemorrhage",
"     </li>",
"     <li>",
"      Other causes: acute severe menorrhagia, genital trauma",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Important factors to consider in the history include patient age, the characteristics of the bleeding (eg, severity, duration, onset), the possibility of pregnancy, associated symptoms including bleeding at other sites, any systemic disease, and medications (particularly those affecting coagulation or platelet function). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The physical examination is directed at uncovering evidence of significant blood loss and identifying the underlying etiology of genital tract bleeding. Remember that a pelvic examination is",
"      <strong>",
"       not",
"      </strong>",
"      performed on women in their third trimester of pregnancy with vaginal bleeding because of the risk of causing separation of a placenta previa. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Obtain a blood sample for type and crossmatch for any woman with severe or symptomatic vaginal bleeding who may require transfusion; for less severe but concerning hemorrhage, a blood type and screen is generally sufficient. A qualitative urine pregnancy test (hCG) should be obtained in any woman of childbearing age with vaginal bleeding whose pregnancy status is in doubt. A positive test is followed by an ultrasound examination. Other studies are obtained based upon clinical circumstances.",
"     </li>",
"     <li>",
"      Many conditions cause genital tract bleeding. A list of such conditions organized by severity and frequency is included in the text. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The patient with vaginal bleeding is approached systematically based upon the answers to a few simple questions (",
"      <a class=\"graphic graphic_algorithm graphicRef77923 \" href=\"UTD.htm?43/38/44640\">",
"       algorithm 1",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Is the patient hemodynamically unstable?",
"     </li>",
"     <li>",
"      Is the patient pregnant? If yes, is it the first trimester, or later in the pregnancy?",
"     </li>",
"     <li>",
"      If not pregnant, what are the most important diagnoses to consider in this patient's age group?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemodynamically unstable patients are resuscitated in standard fashion, including: airway assessment, placement of two large bore (14 gauge or larger) peripheral intravenous lines (IVs), and preparation for transfusion. Determine pregnancy status immediately. Pregnant patients with hemodynamic instability from blood loss (eg, ruptured ectopic pregnancy) require immediate obstetrical consultation and often surgery or delivery. Further diagnostic work-up based upon pregnancy status and patient age are detailed in the text. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnostic approach and disposition'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20920/abstract/1\">",
"      Chimbira TH, Anderson AB, Turnbull Ac. Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. Br J Obstet Gynaecol 1980; 87:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20920/abstract/2\">",
"      Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol 2004; 190:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20920/abstract/3\">",
"      Lane DE. Polycystic ovary syndrome and its differential diagnosis. Obstet Gynecol Surv 2006; 61:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20920/abstract/4\">",
"      Clark TJ, Voit D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002; 288:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20920/abstract/5\">",
"      Fishman A, Paldi E. Vaginal bleeding in premenarchal girls: a review. Obstet Gynecol Surv 1991; 46:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20920/abstract/6\">",
"      Kalinski MA, Guss DA. Hemorrhagic shock from a ruptured ectopic pregnancy in a patient with a negative urine pregnancy test result. Ann Emerg Med 2002; 40:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20920/abstract/7\">",
"      Barnhart K, Mennuti MT, Benjamin I, et al. Prompt diagnosis of ectopic pregnancy in an emergency department setting. Obstet Gynecol 1994; 84:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20920/abstract/8\">",
"      Taipale P, Hiilesmaa V, Yl&ouml;stalo P. Transvaginal ultrasonography at 18-23 weeks in predicting placenta previa at delivery. Ultrasound Obstet Gynecol 1998; 12:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20920/abstract/9\">",
"      Nielsen S, Hahlin M. Expectant management of first-trimester spontaneous abortion. Lancet 1995; 345:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20920/abstract/10\">",
"      Lipscomb GH, McCord ML, Stovall TG, et al. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med 1999; 341:1974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20920/abstract/11\">",
"      Dart RG, Mitterando J, Dart LM. Rate of change of serial beta-human chorionic gonadotropin values as a predictor of ectopic pregnancy in patients with indeterminate transvaginal ultrasound findings. Ann Emerg Med 1999; 34:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20920/abstract/12\">",
"      Hickey M, Higham J, Fraser IS. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation. Cochrane Database Syst Rev 2000; :CD001895.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 286 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-8D13A6BE0D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20920=[""].join("\n");
var outline_f20_27_20920=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24398144\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ANCILLARY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pregnancy tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pelvic ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Additional tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSTIC APPROACH AND DISPOSITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Basic questions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Determine hemodynamic status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Determine pregnancy status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Determine differential diagnosis based on age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24398144\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/286\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/286|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?43/38/44640\" title=\"algorithm 1\">",
"      Approach to vaginal bleeding in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/286|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/26/35246\" title=\"figure 1\">",
"      Hormones and menses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/286|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/2/14379\" title=\"table 1\">",
"      Assessing menstrual blood loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/45/26334\" title=\"table 2\">",
"      Causes genital tract bleeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/12/30924\" title=\"table 3\">",
"      Causes genital bleeding by age",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=related_link\">",
"      Approach to the adult patient with a bleeding diathesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=related_link\">",
"      Approach to women with symptoms of vaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/18/29992?source=related_link\">",
"      Causes, presentation, and evaluation of sellar masses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20122?source=related_link\">",
"      Chronic menorrhagia or anovulatory uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35032?source=related_link\">",
"      Clinical features, diagnosis, and course of placenta previa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=related_link\">",
"      Clinical manifestations of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=related_link\">",
"      Clinical manifestations of polycystic ovary syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1178?source=related_link\">",
"      Clinical manifestations, diagnosis, and management of ectopic pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24794?source=related_link\">",
"      Clinical presentation and diagnosis of von Willebrand disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/27/18874?source=related_link\">",
"      Endometrial carcinoma: Epidemiology and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/10/7336?source=related_link\">",
"      Endometrial polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=related_link\">",
"      Evaluation and management of lower genital tract trauma in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/40/9863?source=related_link\">",
"      Evaluation and management of ruptured ovarian cyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/25/20887?source=related_link\">",
"      Initial approach to the premenopausal woman with abnormal uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/2/11305?source=related_link\">",
"      Managing an episode of severe or prolonged uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=related_link\">",
"      Normal puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23690?source=related_link\">",
"      Ovarian and fallopian tube torsion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/18/35113?source=related_link\">",
"      Overview of causes of genital tract bleeding in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/38/42600?source=related_link\">",
"      Overview of postpartum hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15465?source=related_link\">",
"      Overview of the etiology and evaluation of vaginal bleeding in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27685?source=related_link\">",
"      Physiology of the normal menstrual cycle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29417?source=related_link\">",
"      Placental abruption: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40648?source=related_link\">",
"      Prevention of Rh(D) alloimmunization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/49/2841?source=related_link\">",
"      Spontaneous abortion: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/23/19834?source=related_link\">",
"      Spontaneous abortion: Risk factors, etiology, clinical manifestations, and diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/24/23944?source=related_link\">",
"      Terminology and evaluation of abnormal uterine bleeding in premenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/24/34184?source=related_link\">",
"      Ultrasonography of pregnancy of unknown location",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/29/26072?source=related_link\">",
"      Vulvovaginal complaints in the prepubertal child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_27_20921="Pathogenesis and types of occult spinal dysraphism";
var content_f20_27_20921=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis and types of occult spinal dysraphism",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20921/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20921/contributors\">",
"     Chaouki Khoury, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20921/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20921/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20921/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20921/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/27/20921/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 25, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H19223347\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neural tube defects are congenital anomalies of neural development with a spectrum of clinical manifestations; they can affect the cranium or spine. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cranial defects include anencephaly, exencephaly, and encephalocele. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/57/3991?source=see_link\">",
"       \"Primary (congenital) encephalocele\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/62/11237?source=see_link\">",
"       \"Anencephaly\"",
"      </a>",
"      .) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Open spinal dysraphism (spina bifida aperta) is characterized by a cleft in the spinal column, with herniation of the meninges (meningocele) or meninges and spinal cord (myelomeningocele) through the defect. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=see_link\">",
"       \"Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26344?source=see_link\">",
"       \"Overview of the management of myelomeningocele (spina bifida)\"",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      Closed spinal dysraphism (spina bifida occulta) is characterized by unexposed neural tissue. The abnormalities range from isolated defects in the vertebral column due to abnormal fusion of the posterior arches, to spinal cord malformations such as split spinal cord malformation or various cavitary defects of the spinal cord, and are the subject of this topic review.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19223354\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Open or closed spinal dysraphism occurs at a frequency of 0.5 to 8 cases per 1000 live births [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/1\">",
"     1",
"    </a>",
"    ]. The incidence varies substantially across populations, in patterns that follow nutritional, geographic, and ethnic factors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/35/25145?source=see_link&amp;anchor=H2#H2\">",
"     \"Prenatal screening and diagnosis of neural tube defects\", section on 'Incidence and epidemiology'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    There is no unified risk factor for all occult spinal dysraphic lesions, and insults at different stages of development of the nervous system may lead to one or more dysraphic lesion. Risk factors have been identified for specific types of dysraphic lesions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       Folic acid",
"      </a>",
"      deficiency (whether caused by dietary deficiency, folic acid antagonists, or genetic abnormalities of folate metabolism), has been clearly associated with open spinal dysraphism (myelomeningocele), and the benefit of folic acid supplementation has been established [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/2\">",
"       2",
"      </a>",
"      ]. However, no studies have specifically addressed whether there is a relationship between folic acid deficiency and closed spinal dysraphism [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=see_link\">",
"       \"Folic acid for prevention of neural tube defects\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Maternal diabetes has been associated with increased incidence of the syndrome of caudal regression, but the exact mechanism remains unclear [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/4-6\">",
"       4-6",
"      </a>",
"      ]. The incidence of caudal regression syndrome in the infants of diabetic mothers is 1 to 2 per thousand, whereas its incidence in the general population is 0.05 to 0.1 per thousand [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/7\">",
"       7",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H19221559\">",
"       'Caudal regression or sacral agenesis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Maternal exposure to certain medications has also been associated with spinal dysraphism in the fetus. As an example, maternal exposure to valproate or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      has been associated with spina bifida in their offspring, both in humans and rodent models [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/8-10\">",
"       8-10",
"      </a>",
"      ]. The human studies generally focused on open rather than closed spinal dysraphism. The effects of these anticonvulsant drugs may be mediated through alterations in",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      metabolism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22633?source=see_link&amp;anchor=H5#H5\">",
"       \"Risks associated with epilepsy and pregnancy\", section on 'Fetal and neonatal effects'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221419\">",
"    <span class=\"h1\">",
"     NORMAL CORD DEVELOPMENT IN HUMANS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neural tube defects can arise from abnormalities occurring during several different stages of neural tube development. The embryology of neural tube development helps to explain many of the clinical findings, although the exact mechanisms underlying the development of many of these defects are not fully understood. &nbsp; &nbsp;",
"    <strong>",
"     &nbsp;",
"    </strong>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221931\">",
"    <span class=\"h2\">",
"     Notochord development",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial phase of development of the human nervous system starts with the formation of the notochord on day 17 of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/7\">",
"     7",
"    </a>",
"    ]. The notochord then secretes signaling molecules, such as the Sonic Hedgehog (Shh) protein, which induce the overlying ectoderm to differentiate into neuroectoderm (",
"    <a class=\"graphic graphic_figure graphicRef72061 \" href=\"UTD.htm?35/47/36598\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/11\">",
"     11",
"    </a>",
"    ]. The neuroectoderm produces precursor cells of all neural structures in the developing embryo, while the notochord itself becomes the axis of the developing vertebral column and also contributes to the formation of the nucleus pulposus of the intervertebral disc [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/7,12\">",
"     7,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The endodermally-derived yolk sac is initially connected with the ectodermally-derived amnion through a primitive neurenteric canal (PNC). The PNC exists only temporarily and normally disappears to allow continued normal embryonic development. However, some inciting event may lead to persistence of adhesions between the endoderm and ectoderm, known as the accessory neurenteric canal (ANC) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Depending on which part of the ANC fails to regress, several different clinical anomalies may result, including anomalous development of the vertebrae and spinal cord, anomalies of the gastrointestinal tract such as malrotation and neuroenteric fistula, and genitourinary malformations. The spinal dysraphic lesions include: split notochord syndrome, neurenteric cysts, dorsal dermal sinus tracts and cysts, sacral meningeal cysts, and certain types of split spinal cord syndrome. (See",
"    <a class=\"local\" href=\"#H19221435\">",
"     'Anomalies of notochord development'",
"    </a>",
"    below.) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221938\">",
"    <span class=\"h2\">",
"     Primary neurulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary neurulation is the process of forming a tube from the neuroectodermal tissue (",
"    <a class=\"graphic graphic_figure graphicRef72061 \" href=\"UTD.htm?35/47/36598\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/1\">",
"     1",
"    </a>",
"    ]. The neuroectoderm begins as a flat neural plate, which invaginates as its lateral ends elevate and come together to fuse to form the primary neural tube (PNT).",
"   </p>",
"   <p>",
"    Fusion starts on day 21 of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/3\">",
"     3",
"    </a>",
"    ]. The fusion begins in the middle of the neural plate and then proceeds both rostrally and caudally to form the PNT. The PNT initially has openings at both ends, known as the anterior (cranial) and posterior (caudal) neuropores. The anterior neuropore closes first at around 25 days GA, followed by the posterior neuropore at around 27 days GA (",
"    <a class=\"graphic graphic_figure graphicRef81711 \" href=\"UTD.htm?20/24/20879\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    As the neural tube is closing, mesenchymal cells migrate between and separate the developing neural tube from the overlying ectoderm. These mesenchymal cells will form the meninges, neural arches of the vertebrae, paraspinal muscles, and dermis. In addition some cells detach themselves from the closing edges of the neural plate and form the neural crest cells, which have pluripotent potential [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/15\">",
"     15",
"    </a>",
"    ]. As the posterior neuropore closes, the process of primary neurulation is completed [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/1,16\">",
"     1,16",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Failure of the caudal neuropore to close causes spina bifida (myelomeningocele) and spina bifida occulta, the most common neural tube defects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=see_link\">",
"     \"Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H19221504\">",
"     'Abnormalities of primary neurulation'",
"    </a>",
"    below.) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221945\">",
"    <span class=\"h2\">",
"     Secondary neurulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The process of secondary neurulation begins by addition of a terminal segment to the caudal end of the PNT. The two segments join at approximately the level of future sacral segment 2 (S2) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/17\">",
"     17",
"    </a>",
"    ]. The terminal segment derives from the caudal cell mass (or tail bud), which is a collection of undifferentiated mesodermal cells from which arise the caudal ends of the spinal cord, notochord and GI tract, the caudal somites, the caudal neural crest cells derivatives, and the blood vessels supplying all these structures [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/1,16\">",
"     1,16",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The cavity of the SNT forms through two different processes. At the junction of the PNT and SNT, the cavity of the PNT grows into the SNT. However, more distally, multiple small cavities form within the SNT independently and coalesce together and with the growing PNT cavity, to form a continuous cavity that spans both the PNT and the SNT [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While the structures of the caudal SNT are undergoing apoptosis to form the cavity within the SNT, a thin fibrous layer remains connected to the PNT. This is a continuation of the pia mater and dura mater, known as the filum terminale [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/16\">",
"     16",
"    </a>",
"    ]. The most caudal end of the spinal cord, to which the filum terminale is attached, becomes known as the conus medullaris, and its cavity becomes known as the ventriculus terminale [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/1,16\">",
"     1,16",
"    </a>",
"    ]. The ventriculus terminale usually regress by term, but may occasionally persist, asymptomatically into adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/15\">",
"     15",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Disruption of secondary neurulation leads to spinal cord anomalies that are covered by skin; they include tethered cord syndrome, terminal diplomyelia, sacrococcygeal teratomas, and sacral agenesis. (See",
"    <a class=\"local\" href=\"#H19221527\">",
"     'Anomalies of the caudal cell mass and secondary neurulation'",
"    </a>",
"    below.) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19222092\">",
"    <span class=\"h2\">",
"     Molecular mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the basic structure of the spinal cord is developing through primary neurulation, the developing cord is actively undergoing ventrodorsal and rostrocaudal differentiation, guided by chemical gradients of different signaling molecules secreted by the surrounding structures. These signaling molecules control the expression of transcription factors by the developing neural cells: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fibroblast Growth Factor (FGF) is secreted by the paraxial mesoderm in a decreasing caudorostral gradient. FGF maintains immaturity of the neural progenitor cells in the caudal area, allowing continued growth of the caudal spinal cord, while the decreasing FGF gradient in the rostral direction allows maturation of the spinal cord in a rostrocaudal sequence. This is done through differential promotion and inhibition of the expression of genes of the homeobox family (eg, Sax1), paired box family (eg, Pax6), Iroquois family (eg, Irx3) and other proneural genes (eg, Cash4). &nbsp;",
"     </li>",
"     <li>",
"      Sonic hedgehog (Shh) and retinoic acid (RA) oppose the action of FGF and promote the rostrocaudal maturation of the spinal cord. In addition, they promote the dorsoventral differentiation of the developing spinal cord, through opposite decreasing (RA) and increasing (Shh) dorsoventral gradients. The dorsal spinal cord differentiates into the alar plate under the influence of RA, while the ventral spinal cord differentiates into the basal or motor plate under the influence of SHH. This is done through the regulation of expression of yet another set of transcription factor genes belonging to the homeodomain family (such as Nkx2 and Nkx6), which are upregulated by SHH [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Spatial and temporal differences in the expression of the homeobox genes are central to the process of secondary neurulation. These genes regulate the growth of the SNT, the apoptotic activity that leads to cavitation and elongation of the neural tube cavity across the PNT and SNT, and the development and then regression of the fetal tail.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Given the delicate interplay of molecular gradients that control the growth and differentiation of the spinal cord, it is easy to understand how minor disturbances in the microenvironment of the developing nervous system can result in congenital anomalies of varying severity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221442\">",
"    <span class=\"h1\">",
"     TYPES OF OCCULT SPINAL DYSRAPHIC ANOMALIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spinal dysraphic anomalies can be classified into three groups, based on the developmental stage at which they are thought to arise. Although these anomalies are discussed separately, more than one dysraphic state commonly coexists in the same patient [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/14,18\">",
"     14,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathophysiologic explanations for these anomalies are not well established. These theories are challenged by observations of some patients with dysraphic anomalies that are thought to originate at different stages of nervous system development [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/19\">",
"     19",
"    </a>",
"    ]. It is possible that such anomalies coexist because a disruption at one stage of neural development also disrupts later stages of development. Alternatively, the anomalies may have a common genetic or environmental trigger. However, it is possible that the proposed pathophysiology does not apply to humans, because they are largely based on studies of mammal and non-mammal vertebrates, especially mice and chick embryos.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221435\">",
"    <span class=\"h2\">",
"     Anomalies of notochord development",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each of the anomalies in this category are thought to be caused by persistence of the accessory neurenteric canal (ANC) connecting the endoderm and ectoderm during development of the notochord. Depending on whether and which part of the ANC is resorbed, several different clinical anomalies may result, including anomalous development of the vertebrae and spinal cord, anomalies of the gastrointestinal tract such as malrotation and neuroenteric fistula, and genitourinary malformations: &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12518966\">",
"    <span class=\"h3\">",
"     Persistence of the anterior part of the ANC",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10600692\">",
"    <span class=\"h4\">",
"     Neurenteric cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurenteric cysts result from persistence of the anterior part of the ANC, with resorption of its dorsal part [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/14,20\">",
"     14,20",
"    </a>",
"    ]. As expected, these malformations are usually associated with a split notochord [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/21\">",
"     21",
"    </a>",
"    ]. The persistence of such a cyst with its connection to the intestines may lead to intestinal anomalies such as malrotation or even duplication [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12518982\">",
"    <span class=\"h3\">",
"     Persistence of the intermediate part of the ANC",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12518957\">",
"    <span class=\"h4\">",
"     Split notochord syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The split notochord syndrome results from persistence of the intermediate part of the ANC, which forces the notochord to follow an abnormal development pattern around the adhesion, resulting in a split notochord [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/20\">",
"     20",
"    </a>",
"    ]. This may lead to anomalous development of the spinal cord and surrounding mesoderm, with extensive defects and an open dysraphic state [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/20\">",
"     20",
"    </a>",
"    ], and abnormal vertebral bodies [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/14,22\">",
"     14,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The vertebral defects associated with split notochord syndrome range in severity from a mere vertebral cleft or bifid vertebrae (which when it affects the posterior vertebral element is referred to as spina bifida occulta), to hemivertebrae, block or fused vertebrae (such as in the Klippel-Feil anomaly), hypertrophic or hyperplastic vertebrae and butterfly vertebrae, to absent vertebrae, and in the most severe form may also lead to partial or total sacral agenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/3,7,14\">",
"     3,7,14",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Total sacral agenesis is usually associated with extensive defects in all structures that arise from the caudal cell mass, and is known as the caudal regression syndrome. (See",
"    <a class=\"local\" href=\"#H19221559\">",
"     'Caudal regression or sacral agenesis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10600759\">",
"    <span class=\"h4\">",
"     Split spinal cord malformation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Split spinal cord malformation (SSCM) is the current term to describe anomalies in which there is splitting or duplication of the spinal cord. Terms used in the past literature include diastematomyelia, diplomyelia, pseudodiplomyelia and dimyelia; these terms were used inconsistently and at times interchangeably. SSCM is thought to arise when the persistent intermediate part of the ANC causes the neural placode to split and not just the notochord. SSCM may present at any age, and is 1.3 to 6 times more frequent in women as compared to men.",
"   </p>",
"   <p>",
"    SSCM is divided into two types. The percentage of type I SSCM reported in the literature is highly variable, ranging from 30 to 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/14,23\">",
"     14,23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In type I, previously called diastematomyelia, each hemicord has a full thecal sac and meningeal covering, and they are separated by a bony spur, forming a double spinal canal. This is thought to occur when there are precursor meningeal cells in the ANC around which the spinal cord splits. These meningeal cells contribute to the formation of the medial aspect of the thecal sac around the two developing hemicords, while the lateral aspect of the sac develops normally around the two hemicords. The ANC persists and forms the bony ridge between the two thecal sacs. The bony spur between the hemicords may be perfectly median, dividing the cord into two symmetric hemicords, or it may be asymmetric, dividing it into a larger functional cord, and a smaller non-functional one. An asymmetric spur has been reported in 10 to 50 percent of SSCM I cases in the literature. The hemicords usually join below the level of the spur, but this is not always the case.",
"     </li>",
"     <li>",
"      In type II SSCM, often called diplomyelia in older terminology, the two hemicords are surrounded by one thecal sac and there is a single spinal canal. The hemicords are generally symmetrical and may be separated by a fibrous band which is the length of one or two vertebral segments. This pattern is thought to occur when no meningeal precursor cells are incorporated in the ANC. In this case, the ANC tends to disappear completely, or persists only as the fibrous tract between the hemicords.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A different embryological theory has been proposed to explain a terminal SSCM type II anomaly (or terminal diplomyelia); this anomaly is thought to be caused by abnormal secondary neurulation, and is discussed separately. (See",
"    <a class=\"local\" href=\"#H19221543\">",
"     'Terminal diplomyelia'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12519286\">",
"    <span class=\"h4\">",
"     Sacral meningeal cysts or sacral meningocele",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sacral cysts are thought to arise when the ANC partially resorbs both ventrally and dorsally, leaving only a cyst-like structure, with no connection to the intestines or skin. This cyst-like structure is incorporated in the mesenchyma destined to form the sacrum, forming a sacral cyst [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/14,20\">",
"     14,20",
"    </a>",
"    ]. The spinal meninges can then herniate into this defect, forming a sacral meningocele [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sacral meningeal cysts usually communicate freely with the subarachnoid space and are known as perineural or Tarlov cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/7\">",
"     7",
"    </a>",
"    ]. Most of these cysts are asymptomatic; cysts that do not communicate with the subarachnoid space are more likely to cause symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/24\">",
"     24",
"    </a>",
"    ]. In a study of 500 consecutive lumbar magnetic resonance imaging studies obtained for different reasons, sacral cysts were noted to occur in five percent of imaged patients [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12519007\">",
"    <span class=\"h3\">",
"     Persistence of the posterior part of the ANC",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221472\">",
"    <span class=\"h4\">",
"     Dorsal dermal sinus tracts and cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the dorsal part of the ANC persists, the remaining cyst keeps its ectodermal connection, leading to dorsal dermal sinuses, cysts, and tracts (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79251 \" href=\"UTD.htm?25/35/26160\">",
"     image 1",
"    </a>",
"    ), with their associated cutaneous anomalies including lumbosacral infantile hemangiomas and sacrococcygeal dimples or pits (",
"    <a class=\"graphic graphic_table graphicRef76756 \" href=\"UTD.htm?5/3/5179\">",
"     table 1",
"    </a>",
"    ). This pattern is known as dysraphic cutaneous syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/14,20\">",
"     14,20",
"    </a>",
"    ]. The dorsal dermal sinuses occur with a frequency of around 1 in 2500 live births and are most commonly found in the lumbosacral area (around 10 percent and 1 percent occurring in the thoracic and cervical areas, respectively). Of note, these cutaneous lesions are often associated with spina bifida occulta, with the bifid vertebra lying at the level of entry of the tract into the dural space [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H19221511\">",
"     'Spina bifida occulta'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Dysraphic cutaneous syndrome typically has one or more of three clinical presentations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most commonly, they come to medical attention because of a midline dimple, pit or hemangioma (",
"      <a class=\"graphic graphic_picture graphicRef72298 \" href=\"UTD.htm?17/3/17471\">",
"       picture 1",
"      </a>",
"      ), usually above the top of the intergluteal fold. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/21/24922?source=see_link&amp;anchor=H44#H44\">",
"       \"Assessment of the newborn infant\", section on 'Trunk and spine'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Some patients come to medical attention when they develop meningitis; the infection tends to be with unusual organisms.",
"     </li>",
"     <li>",
"      Other patients present with a neurological deficit, which often is progressive [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/18\">",
"       18",
"      </a>",
"      ]. The neurological deficit can be due to different causes. Commonly it is due to cord tethering, either by the tract itself, or by an associated inelastic filum [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/3,18\">",
"       3,18",
"      </a>",
"      ]. In addition, inclusion masses which are associated with these lesions in 35 to 55 percent of cases may compress the spinal cord. These masses usually are dermoid, epidermoid, or teratoid tumors. The neurological deficit can also be due to infection, such as an epidural abscess compressing the cord. It should be finally noted that the tract of the dorsal dermal sinus may terminate anywhere from outside the vertebral column, to the extradural, subdural, and subarachnoid spaces, or even on the nerve roots, filum or cord itself. Therefore probing of the sinus or a fistulogram should never be performed [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221504\">",
"    <span class=\"h2\">",
"     Abnormalities of primary neurulation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221496\">",
"    <span class=\"h3\">",
"     Syringohydromyelia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two forms of syringohydromyelia are defined. The embryonic form consists of abnormal dilatation of the central canal of the spinal cord, with thinning and expansion of the roof plate, and absence or near-absence of mesenchymal tissue between the roof plate and the overlying ectoderm, causing a gap in the posterior vertebral arches (",
"    <a class=\"graphic graphic_picture graphicRef76565 \" href=\"UTD.htm?29/26/30118\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By contrast, the hydromyelia that develops at the fetal stage or later does not affect mesenchymal tissue development and is usually associated with an intact vertebral column. It may be asymptomatic, and is sometimes identified only incidentally in otherwise normal adults. In this latter case, it is termed &ldquo;idiopathic localized hydromyelia&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/26\">",
"     26",
"    </a>",
"    ]. This lesion could result from excessive secretion of CSF into the spinal canal, or may also be caused by acquired lesions of the spinal cord, including infection, tumor, or trauma. Similar lesions are also seen as part of a syndrome with other associated abnormalities, not related to the development of the syringohydromyelia per se (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51001 \" href=\"UTD.htm?23/13/23763\">",
"     image 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link&amp;anchor=H33#H33\">",
"     \"Disorders affecting the spinal cord\", section on 'Syringomyelia'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221511\">",
"    <span class=\"h3\">",
"     Spina bifida occulta",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spina bifida is defined as a failure of fusion of the vertebral bodies dorsal to the spinal cord. When the overlying skin is intact, this defect is termed closed spina bifida or spina bifida occulta. Radiographic findings in addition to the defect in the posterior vertebral arches may include widening of the spinal canal, fusion of the vertebral bodies, and fused or malformed laminae. Minor abnormalities of the overlying skin are common, including nevi, dermal sinus or dimple, hemangioma, underlying lipoma, or a hirsute area (",
"    <a class=\"graphic graphic_table graphicRef76756 \" href=\"UTD.htm?5/3/5179\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/27\">",
"     27",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/21/24922?source=see_link&amp;anchor=H180221208#H180221208\">",
"     \"Assessment of the newborn infant\", section on 'Sacral dimple'",
"    </a>",
"    ). Spina bifida occulta may be isolated or coexistent with other spinal cord anomalies, such as cysts or a tethered cord. &nbsp;",
"   </p>",
"   <p>",
"    Of note, the normal neural arch ossification is not complete until the age of two to three years. Therefore, an incompletely ossified neural arch in a child younger than three years of age should not be mistaken for spina bifida occulta [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/28\">",
"     28",
"    </a>",
"    ]. In addition, an incompletely ossified dorsal neural arch is a normal variant seen in 20 to 30 percent of healthy individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/3\">",
"     3",
"    </a>",
"    ]. This type of vertebral variation is not considered a form of spinal dysraphism, although it is described as spina bifida occulta by a few authors.",
"   </p>",
"   <p>",
"    When the overlying skin is not intact, the meninges",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    spinal cord herniate through the defect. This is termed open spina bifida, spina bifida aperta, or spina bifida cystica [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/15,29\">",
"     15,29",
"    </a>",
"    ]. If only meninges are herniated, this forms a meningocele, while if both meninges and spinal cord herniate through the defect, a myelomeningocele is formed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=see_link\">",
"     \"Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221519\">",
"    <span class=\"h3\">",
"     Spinal lipomas and teratomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spinal lipomas (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51304 \" href=\"UTD.htm?33/26/34211\">",
"     image 3",
"    </a>",
"    ) occur in around 1 in 4000 live births [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/30\">",
"     30",
"    </a>",
"    ]. These tumors probably arise from abnormal mesodermal cells that failed to normally migrate and remained trapped between the roof plate and the ectoderm [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/15,31\">",
"     15,31",
"    </a>",
"    ]. They often contain multiple types of tissue, so they can be considered complex teratomas [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Progressive neurological dysfunction in patients with lumbosacral lipomas may be caused by compression of the spinal cord by the lipoma, or by tethered spinal cord, which frequently coexists in the same patient. In addition, most patients with spinal lipomas have malformations of the spinal cord and its roots (68 percent) or vertebral column (spina bifida, 80 percent; sacral agenesis, 25 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/32\">",
"     32",
"    </a>",
"    ]. Most patients have cutaneous stigmata, such as a subcutaneous lump, dermal sinus or lumbosacral hemangioma (",
"    <a class=\"graphic graphic_picture graphicRef72298 \" href=\"UTD.htm?17/3/17471\">",
"     picture 1",
"    </a>",
"    ). A significant minority have associated anomalies of the urogenital or gastrointestinal systems. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5495?source=see_link&amp;anchor=H11#H11\">",
"     \"Evaluation and diagnosis of infantile hemangiomas\", section on 'Lumbosacral'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221527\">",
"    <span class=\"h2\">",
"     Anomalies of the caudal cell mass and secondary neurulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;This group of anomalies are thought to result from abnormal development of the caudal cell mass (caudal eminence), and hence of secondary neurulation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/33\">",
"     33",
"    </a>",
"    ]. As a result, this group of anomalies is less likely to be associated with skin stigmata, because primary neurulation and ectodermal development is usually complete by the time that the caudal cell mass develops [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In other cases, these anomalies may be a secondary consequence of abnormal notochord development, and are found with anomalies from that stage of development, including skin stigmata [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H19221435\">",
"     'Anomalies of notochord development'",
"    </a>",
"    above.) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221535\">",
"    <span class=\"h3\">",
"     Tethered cord syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tethered cord syndrome (TCS) is stretch-induced dysfunction of the caudal spinal cord and conus, caused by attachment of the filum terminale to inelastic structures caudally (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75372 \" href=\"UTD.htm?20/32/20995\">",
"     image 4",
"    </a>",
"    ). TCS may occur independently or in association with any of the other dysraphic lesions, whether open or closed [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/3\">",
"     3",
"    </a>",
"    ]. When TCS occurs independently, it is usually due to anomalous regression of the human tail, part of the normal involution of the caudal cell mass [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/3,34\">",
"     3,34",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The filum terminale is normally viscoelastic in nature, and serves to dampen movements of the spine during flexion and extension, without applying undue traction to the moving spinal cord [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/34\">",
"     34",
"    </a>",
"    ]. In TCS, the spinal cord is attached to abnormally inelastic structures caudally, such as a fibrous or fat-infiltrated filum, tumor, meningoceles or myelomeningoceles, scars, or septa (as seen in SSCM). This causes the caudal portion of the spinal cord to stretch between the point of tethering and the dentate ligaments that fix the cord proximally [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/35\">",
"     35",
"    </a>",
"    ]. Progressive dysfunction occurs because of repeated extension or flexion of the spine. The progressive dysfunction has also been attributed to differential growth of the vertebral column as compared to the spinal cord [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/35\">",
"     35",
"    </a>",
"    ], but there is controversy on this point [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/34\">",
"     34",
"    </a>",
"    ]. &nbsp; &nbsp; &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    In the short term, stretching of the spinal cord causes biochemical and electrophysiological changes that are still reversible if the stretch is released surgically [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. The severity of the biochemical and electrophysiological abnormalities is found to be proportionate to the degree of stretching in animal models, and proportionate to the severity of the clinical symptoms in humans. In the long term, the stretching of the spinal cord leads to neuronal degeneration and regeneration, and the neurological deficits may become irreversible [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/35,37\">",
"     35,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In toddlers and children, TCS typically presents with progressive motor and sensory dysfunction, which may include gait abnormalities and loss of bladder control [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/38\">",
"     38",
"    </a>",
"    ]. Older children and adolescents are more likely to complain of pain in the lumbosacral region, perineum, and legs. TCS causes spinal dysfunction caudal to T12-L1, and does not explain upper motor neuron signs. If upper motor neuron signs are present (eg, spasticity or hyperreflexia), the patient should be evaluated for a more proximal lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/37\">",
"     37",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    TCS is also seen in adults, and the biochemical and electrophysiological changes are similar to those identified in children. In adults as in children, TCS may be associated with spinal dysraphism, or it may occur independently. If there is no associated dysraphism, TCS may be difficult to diagnose, because neuroimaging is normal in up to 50 percent of patients with TCS [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/36,39\">",
"     36,39",
"    </a>",
"    ]. Back pain, leg pain and scoliosis are the primary symptoms of TCS in adults, and these symptoms may be difficult to distinguish from other more common causes of chronic back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/39\">",
"     39",
"    </a>",
"    ]. Somatosensory symptoms tend to be subtle. If patients with these symptoms have associated sphincteric dysfunction, they should be evaluated for TCS. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221543\">",
"    <span class=\"h3\">",
"     Terminal diplomyelia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Terminal diplomyelia refers to duplication or splitting of the terminal spinal cord. This anomaly is not always symptomatic, and may be incidentally seen in otherwise healthy children [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/1\">",
"     1",
"    </a>",
"    ]. Terminal diplomyelia is considered to be an anomaly of secondary neurulation, caused by abnormal cavitation in the SNT. The multiple cavities do not coalesce with each other normally, resulting in persistence of more than one cavity which leads to canal duplication or forking, affecting the conus medullaris, ventriculus terminalis and filum terminalis.",
"   </p>",
"   <p>",
"    By contrast, split spinal cord malformation (SSCM) occurs rostral to the caudal cord, and the spinal cord proximal and distal to the lesion is normal. SSCM is thought to be caused by faulty primary neurulation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10600759\">",
"     'Split spinal cord malformation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221551\">",
"    <span class=\"h3\">",
"     Sacrococcygeal teratomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Teratomas are tumors that comprise tissues of all three germ layers, or that include tissues foreign to the neoplasm&rsquo;s site of origin. Sacrococcygeal teratomas are thought to arise from totipotent somatic stem cells within the caudal cell mass that do not differentiate normally due to an interruption of the normal signaling pathways [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sacrococcygeal teratomas occur more commonly in females, but carry a higher malignant potential in males [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/5\">",
"     5",
"    </a>",
"    ]. They are the most common neoplasm in the neonate, with an incidence of 25 to 30 per 1,000,000 live births. Sacrococcygeal teratomas recur after resection in about 10 percent of patients; tumors that have immature histology or that arise after birth have a guarded prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/30/17894?source=see_link\">",
"     \"Sacrococcygeal germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fetuses with a sacrococcygeal teratoma may require delivery by cesarian section, either because the teratoma is large enough to hinder vaginal delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/5\">",
"     5",
"    </a>",
"    ] or because of the associated obstetric complications such as polyhydramnios, preeclampsia, spotting or rapid weight gain. With the advent of routine ultrasonography at 16 to 18 weeks gestation, many of the tumors are diagnosed in otherwise asymptomatic pregnancies. The appearance of fetal hydrops",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    placentomegaly carries a negative prognosis; once these tumors become symptomatic, the fetal mortality rate increases significantly due to high-output cardiac failure, and fetal surgery is sometimes considered [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/42-45\">",
"     42-45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19221559\">",
"    <span class=\"h3\">",
"     Caudal regression or sacral agenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Caudal regression syndrome consists of a spectrum of structural defects of the caudal region, including incomplete development of the sacrum and sometimes of the lumbar vertebrae. The disorder may be associated with either occult or open spinal dysraphism, and most patients also have cord tethering [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/4\">",
"     4",
"    </a>",
"    ]. This syndrome, whether associated with either occult or open spinal dysraphism, seems to occur with increased incidence in children of mothers with insulin-dependent diabetes, although the mechanisms for this association are not clear [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/5,7,46\">",
"     5,7,46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=see_link&amp;anchor=H8#H8\">",
"     \"Infant of a diabetic mother\", section on 'Neonatal effects'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    If the caudal regression syndrome is associated with occult dysraphism, the bony lesion is at a low spinal level. This pattern is probably caused by abnormal development of the caudal cell mass affecting all tissues that derive from it, including the neural, gastrointestinal, urogenital and musculoskeletal tissues of the caudal vertebral column and lower extremities [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Caudal regression syndrome may also be associated with high bony lesions and an open dysraphic state, with a spinal meningocele, and truncation of the spinal cord. In this case, it is probably caused by abnormal notochord development [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/3,7,14\">",
"     3,7,14",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The clinical presentation of caudal regression syndrome is highly variable, depending on the level of the spinal lesion. Affected infants may appear to have a small pelvis, neurogenic bladder, and variable degrees of limb deformity, depending on the level of the defect (",
"    <a class=\"graphic graphic_picture graphicRef78173 \" href=\"UTD.htm?39/57/40863\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef72545 \" href=\"UTD.htm?14/58/15268\">",
"     picture 4",
"    </a>",
"    ). Caudal regression may also present as part of a syndrome, in which case a wide variety of organ systems can be affected (",
"    <a class=\"graphic graphic_table graphicRef69562 \" href=\"UTD.htm?33/23/34172\">",
"     table 2",
"    </a>",
"    ). These syndromes include [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      VACTERL (",
"      <strong>",
"       V",
"      </strong>",
"      ertebral,",
"      <strong>",
"       A",
"      </strong>",
"      norectal,",
"      <strong>",
"       C",
"      </strong>",
"      ardiac,",
"      <strong>",
"       T",
"      </strong>",
"      racheo-",
"      <strong>",
"       E",
"      </strong>",
"      sophageal fistula,",
"      <strong>",
"       R",
"      </strong>",
"      enal and",
"      <strong>",
"       L",
"      </strong>",
"      imb anomalies). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link&amp;anchor=H2#H2\">",
"       \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\", section on 'Tracheal atresia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      OEIS (",
"      <strong>",
"       O",
"      </strong>",
"      mphalocele, cloacal",
"      <strong>",
"       E",
"      </strong>",
"      xstrophy,",
"      <strong>",
"       I",
"      </strong>",
"      mperforate anus,",
"      <strong>",
"       S",
"      </strong>",
"      pinal malformation). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/21/6488?source=see_link&amp;anchor=H8#H8\">",
"       \"Obstetrical and neonatal management of body stalk anomalies and cloacal abnormalities\", section on 'Cloacal exstrophy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The Currarino syndrome, which consists of a sacral vertebral defect, a presacral mass (such as an anterior sacral meningocele or presacral teratoma), and anorectal malformations [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/5,20\">",
"       5,20",
"      </a>",
"      ]. It is autosomal dominant in inheritance, localizes to 7q36, and mutations of a homeobox gene have been identified in certain families.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The term caudal regression syndrome is sometimes used to include sirenomelia, which consists of sacral agenesis and fused lower extremities (causing the fetus to resemble a mermaid). Sirenomelia is thought to be caused by abnormal shunting of the vitelline artery, causing vascular steal from the abdominal aorta and lower extremity [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/47\">",
"     47",
"    </a>",
"    ]. Whether these disorders have distinct pathogenesis remains controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/48\">",
"     48",
"    </a>",
"    ], though it is more likely that they are different disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20921/abstract/6\">",
"     6",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19488755\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occult spinal dysraphism refers to failure of fusion of the vertebral bodies due to abnormal fusion of the posterior vertebral arches, with unexposed neural tissue. The more common and least severe forms consist of isolated vertebral bony defects. However, the vertebral defects may occur in association with other more severe anomalies of the spinal cord and sacral structures, such as split spinal cord malformation or various cavitary defects of the spinal cord. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with occult spinal dysraphism often have minor abnormalities of the overlying skin, including nevus, dermal sinus or dimple, an underlying lipoma, or a hirsute area. The vertebral lesion may be isolated and asymptomatic (such as in spina bifida occulta), or may be associated with spinal cord anomalies, including a split spinal cord malformation, terminal diplomyelia, or tethered cord syndrome. (See",
"      <a class=\"local\" href=\"#H19221511\">",
"       'Spina bifida occulta'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Split spinal cord malformation (SSCM) describes anomalies where there is splitting or duplication of the spinal cord. In type I SSCM, each hemicord has a full thecal sac and meningeal covering, and they are separated by a bony spur, forming a double spinal canal. In type II SSCM, the two hemicords are surrounded by one thecal sac and there is a single spinal canal. (See",
"      <a class=\"local\" href=\"#H10600759\">",
"       'Split spinal cord malformation'",
"      </a>",
"      above.) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Terminal diplomyelia refers to duplication or splitting of the terminal spinal cord. This anomaly is not always symptomatic, and may be incidentally seen in otherwise healthy children. (See",
"      <a class=\"local\" href=\"#H19221543\">",
"       'Terminal diplomyelia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tethered cord syndrome (TCS) is stretch-induced dysfunction of the caudal spinal cord and conus, caused by attachment of the filum terminale to inelastic structures caudally. TCS may occur in isolation, or in association with other dysraphic lesions (See",
"      <a class=\"local\" href=\"#H19221535\">",
"       'Tethered cord syndrome'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Caudal regression syndrome consists of a spectrum of structural defects of the caudal region, including incomplete development of the sacrum and sometimes of the lumbar vertebrae. An increased frequency of caudal regression has been noted in infants of diabetic mothers. Genetic contributors also seem likely, as suggested by the association of caudal regression with several genetic syndromes. (See",
"      <a class=\"local\" href=\"#H19221559\">",
"       'Caudal regression or sacral agenesis'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/1\">",
"      Saitsu H, Yamada S, Uwabe C, et al. Development of the posterior neural tube in human embryos. Anat Embryol (Berl) 2004; 209:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/2\">",
"      Betteridge KJ. Comparative aspects of conceptus growth: a historical perspective. Reproduction 2001; 122:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/3\">",
"      Michelson DJ, Ashwal S. Tethered cord syndrome in childhood: diagnostic features and relationship to congenital anomalies. Neurol Res 2004; 26:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/4\">",
"      Estin D, Cohen AR. Caudal agenesis and associated caudal spinal cord malformations. Neurosurg Clin N Am 1995; 6:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/5\">",
"      Lynch SA, Wang Y, Strachan T, et al. Autosomal dominant sacral agenesis: Currarino syndrome. J Med Genet 2000; 37:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/6\">",
"      Boulas MM. Recognition of caudal regression syndrome. Adv Neonatal Care 2009; 9:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/7\">",
"      Diel J, Ortiz O, Losada RA, et al. The sacrum: pathologic spectrum, multimodality imaging, and subspecialty approach. Radiographics 2001; 21:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/8\">",
"      Ceylan S, Duru S, Ceylan S. Valproic acid sodium-induced spina bifida occulta in the rat. Neurosurg Rev 2001; 24:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/9\">",
"      Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991; 324:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/10\">",
"      Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/11\">",
"      Lobjois V, Benazeraf B, Bertrand N, et al. Specific regulation of cyclins D1 and D2 by FGF and Shh signaling coordinates cell cycle progression, patterning, and differentiation during early steps of spinal cord development. Dev Biol 2004; 273:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/12\">",
"      Qi BQ, Beasley SW, Frizelle FA. Evidence that the notochord may be pivotal in the development of sacral and anorectal malformations. J Pediatr Surg 2003; 38:1310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/13\">",
"      Proctor MR, Bauer SB, Scott RM. The effect of surgery for split spinal cord malformation on neurologic and urologic function. Pediatr Neurosurg 2000; 32:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/14\">",
"      Schijman E. Split spinal cord malformations: report of 22 cases and review of the literature. Childs Nerv Syst 2003; 19:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/15\">",
"      Ikenouchi J, Uwabe C, Nakatsu T, et al. Embryonic hydromyelia: cystic dilatation of the lumbosacral neural tube in human embryos. Acta Neuropathol 2002; 103:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/16\">",
"      Economides KD, Zeltser L, Capecchi MR. Hoxb13 mutations cause overgrowth of caudal spinal cord and tail vertebrae. Dev Biol 2003; 256:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/17\">",
"      M&uuml;ller F, O'Rahilly R. The development of the human brain, the closure of the caudal neuropore, and the beginning of secondary neurulation at stage 12. Anat Embryol (Berl) 1987; 176:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/18\">",
"      Ackerman LL, Menezes AH, Follett KA. Cervical and thoracic dermal sinus tracts. A case series and review of the literature. Pediatr Neurosurg 2002; 37:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/19\">",
"      Solanki GA, Evans J, Copp A, Thompson DN. Multiple coexistent dysraphic pathologies. Childs Nerv Syst 2003; 19:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/20\">",
"      Ilhan H, Tokar B, Atasoy MA, Kulali A. Diagnostic steps and staged operative approach in Currarino's triad: a case report and review of the literature. Childs Nerv Syst 2000; 16:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/21\">",
"      Ebisu T, Odake G, Fujimoto M, et al. Neurenteric cysts with meningomyelocele or meningocele. Split notochord syndrome. Childs Nerv Syst 1990; 6:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/22\">",
"      van Ramshorst GH, Lequin MH, Mancini GM, van de Ven CP. A case of split notochord syndrome: a child with a neuroenteric fistula presenting with meningitis. J Pediatr Surg 2006; 41:e19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/23\">",
"      Cheng B, Li FT, Lin L. Diastematomyelia: a retrospective review of 138 patients. J Bone Joint Surg Br 2012; 94-B:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/24\">",
"      Davis SW, Levy LM, LeBihan DJ, et al. Sacral meningeal cysts: evaluation with MR imaging. Radiology 1993; 187:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/25\">",
"      Paulsen RD, Call GA, Murtagh FR. Prevalence and percutaneous drainage of cysts of the sacral nerve root sheath (Tarlov cysts). AJNR Am J Neuroradiol 1994; 15:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/26\">",
"      Jinkins JR, Sener RN. Idiopathic localized hydromyelia: dilatation of the central canal of the spinal cord of probable congenital origin. J Comput Assist Tomogr 1999; 23:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/27\">",
"      Guggisberg D, Hadj-Rabia S, Viney C, et al. Skin markers of occult spinal dysraphism in children: a review of 54 cases. Arch Dermatol 2004; 140:1109.",
"     </a>",
"    </li>",
"    <li>",
"     Oh, BC, Wang, MY. Cervical Anatomy and Surgical Approaches. In: Surgery of the Pediatric Spine, Kim, DH, et al (Eds), Thieme Medical Publishers, Inc., New York 2008. p.95.",
"    </li>",
"    <li>",
"     Congress of Neurosurgical Surgeons: file://www.neurosurgeon.org/education/medStudCur/curriculum.asp?inPage=e1",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/30\">",
"      Tubbs RS, Wellons JC 3rd, Oakes WJ. Occipital encephalocele, lipomeningomyelocele, and Chiari I malformation: case report and review of the literature. Childs Nerv Syst 2003; 19:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/31\">",
"      Catala M. Embryogenesis. Why do we need a new explanation for the emergence of spina bifida with lipoma? Childs Nerv Syst 1997; 13:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/32\">",
"      Pierre-Kahn A, Zerah M, Renier D, et al. Congenital lumbosacral lipomas. Childs Nerv Syst 1997; 13:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/33\">",
"      Pang D. Sacral agenesis and caudal spinal cord malformations. Neurosurgery 1993; 32:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/34\">",
"      Tubbs RS, Oakes WJ. Can the conus medullaris in normal position be tethered? Neurol Res 2004; 26:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/35\">",
"      Yamada S, Won DJ, Siddiqi J, Yamada SM. Tethered cord syndrome: overview of diagnosis and treatment. Neurol Res 2004; 26:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/36\">",
"      Yamada S. Tethered cord syndrome in adults and children. Neurol Res 2004; 26:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/37\">",
"      Yamada S, Knerium DS, Mandybur GM, et al. Pathophysiology of tethered cord syndrome and other complex factors. Neurol Res 2004; 26:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/38\">",
"      Hertzler DA 2nd, DePowell JJ, Stevenson CB, Mangano FT. Tethered cord syndrome: a review of the literature from embryology to adult presentation. Neurosurg Focus 2010; 29:E1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/39\">",
"      Yamada S, Lonser RR. Adult tethered cord syndrome. J Spinal Disord 2000; 13:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/40\">",
"      Flake AW. Fetal sacrococcygeal teratoma. Semin Pediatr Surg 1993; 2:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/41\">",
"      De Backer A, Madern GC, Hakvoort-Cammel FG, et al. Study of the factors associated with recurrence in children with sacrococcygeal teratoma. J Pediatr Surg 2006; 41:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/42\">",
"      Perrelli L, D'Urzo C, Manzoni C, et al. Sacrococcygeal teratoma. Outcome and management. An analysis of 17 cases. J Perinat Med 2002; 30:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/43\">",
"      Wilson RD. Prenatal evaluation for fetal surgery. Curr Opin Obstet Gynecol 2002; 14:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/44\">",
"      Wilson RD, Hedrick H, Flake AW, et al. Sacrococcygeal teratomas: prenatal surveillance, growth and pregnancy outcome. Fetal Diagn Ther 2009; 25:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/45\">",
"      Gucciardo L, Uyttebroek A, De Wever I, et al. Prenatal assessment and management of sacrococcygeal teratoma. Prenat Diagn 2011; 31:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/46\">",
"      Wender-Ozegowska E, Wr&oacute;blewska K, Zawiejska A, et al. Threshold values of maternal blood glucose in early diabetic pregnancy--prediction of fetal malformations. Acta Obstet Gynecol Scand 2005; 84:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/47\">",
"      Twickler D, Budorick N, Pretorius D, et al. Caudal regression versus sirenomelia: sonographic clues. J Ultrasound Med 1993; 12:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20921/abstract/48\">",
"      Valenzano M, Paoletti R, Rossi A, et al. Sirenomelia. Pathological features, antenatal ultrasonographic clues, and a review of current embryogenic theories. Hum Reprod Update 1999; 5:82.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14405 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-110.137.129.113-3F22B2A069-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20921=[""].join("\n");
var outline_f20_27_20921=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19488755\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19223347\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19223354\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19221419\">",
"      NORMAL CORD DEVELOPMENT IN HUMANS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19221931\">",
"      Notochord development",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19221938\">",
"      Primary neurulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19221945\">",
"      Secondary neurulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19222092\">",
"      Molecular mechanisms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19221442\">",
"      TYPES OF OCCULT SPINAL DYSRAPHIC ANOMALIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19221435\">",
"      Anomalies of notochord development",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12518966\">",
"      - Persistence of the anterior part of the ANC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H10600692\">",
"      Neurenteric cysts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12518982\">",
"      - Persistence of the intermediate part of the ANC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H12518957\">",
"      Split notochord syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H10600759\">",
"      Split spinal cord malformation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H12519286\">",
"      Sacral meningeal cysts or sacral meningocele",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12519007\">",
"      - Persistence of the posterior part of the ANC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19221472\">",
"      Dorsal dermal sinus tracts and cysts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19221504\">",
"      Abnormalities of primary neurulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19221496\">",
"      - Syringohydromyelia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19221511\">",
"      - Spina bifida occulta",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19221519\">",
"      - Spinal lipomas and teratomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19221527\">",
"      Anomalies of the caudal cell mass and secondary neurulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19221535\">",
"      - Tethered cord syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19221543\">",
"      - Terminal diplomyelia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19221551\">",
"      - Sacrococcygeal teratomas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19221559\">",
"      - Caudal regression or sacral agenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19488755\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/14405\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/14405|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/35/26160\" title=\"diagnostic image 1\">",
"      Dorsal sinus tract",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/13/23763\" title=\"diagnostic image 2\">",
"      Multiseptated cervicothoracic hydrosyringomyelia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/26/34211\" title=\"diagnostic image 3\">",
"      Lumbosacral spinal lipoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/32/20995\" title=\"diagnostic image 4\">",
"      Tethered cord syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/14405|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/47/36598\" title=\"figure 1\">",
"      Primary neurulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/24/20879\" title=\"figure 2\">",
"      Cephalocaudad neurulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/14405|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/3/17471\" title=\"picture 1\">",
"      Lumbosacral hemangioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/26/30118\" title=\"picture 2\">",
"      Syringohydromyelia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/57/40863\" title=\"picture 3\">",
"      Neonate with caudal regression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/58/15268\" title=\"picture 4\">",
"      Caudal regression syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/14405|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/3/5179\" title=\"table 1\">",
"      Cutaneous syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/23/34172\" title=\"table 2\">",
"      Clinical findings in caudal regression syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/62/11237?source=related_link\">",
"      Anencephaly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/21/24922?source=related_link\">",
"      Assessment of the newborn infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=related_link\">",
"      Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=related_link\">",
"      Disorders affecting the spinal cord",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5495?source=related_link\">",
"      Evaluation and diagnosis of infantile hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=related_link\">",
"      Folic acid for prevention of neural tube defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=related_link\">",
"      Infant of a diabetic mother",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/21/6488?source=related_link\">",
"      Obstetrical and neonatal management of body stalk anomalies and cloacal abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26344?source=related_link\">",
"      Overview of the management of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=related_link\">",
"      Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/35/25145?source=related_link\">",
"      Prenatal screening and diagnosis of neural tube defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/57/3991?source=related_link\">",
"      Primary (congenital) encephalocele",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22633?source=related_link\">",
"      Risks associated with epilepsy and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/30/17894?source=related_link\">",
"      Sacrococcygeal germ cell tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_27_20922="Management of coarctation of the aorta";
var content_f20_27_20922=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of coarctation of the aorta",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20922/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20922/contributors\">",
"     Brojendra N Agarwala, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20922/contributors\">",
"     Emile Bacha, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20922/contributors\">",
"     Qi Ling Cao, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20922/contributors\">",
"     Ziyad M Hijazi, MD, MPH, FAAP, FACC, FSCAI, FAHA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20922/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20922/contributors\">",
"     David R Fulton, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20922/contributors\">",
"     Heidi M Connolly, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/27/20922/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20922/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/27/20922/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/27/20922/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coarctation of the aorta is a discrete narrowing of the thoracic aorta just distal to the left subclavian artery. The care of a patient with coarctation depends upon the severity of the coarctation, patient age, and clinical presentation.",
"   </p>",
"   <p>",
"    The management of coarctation of the aorta including corrective treatment options and complications will be reviewed here. The clinical manifestations, natural history, and diagnosis of coarctation of the aorta are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link\">",
"     \"Clinical manifestations and diagnosis of coarctation of the aorta\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management decisions for patients with coarctation of the aorta depend upon patient age, presentation, and the severity of the lesion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Critical coarctation in infancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with severe (&ldquo;critical&rdquo;) coarctation are at-risk for developing heart failure and death when the ductus arteriosus closes. Identification of these patients is essential in order to maintain patency of the ductus prior to surgical repair. In addition, immediate treatment is required to stabilize patients with heart failure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical manifestations and diagnosis of coarctation of the aorta\", section on 'Neonates'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33482?source=see_link&amp;anchor=H270523701#H270523701\">",
"     \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'Critical CHD'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Medical therapy consists of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Continuous intravenous infusion of prostaglandin E1 (also known as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40966?source=see_link\">",
"       alprostadil",
"      </a>",
"      ) to keep the ductus arteriosus open.",
"     </li>",
"     <li>",
"      Dopamine",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      to improve contractility in those with heart failure.",
"     </li>",
"     <li>",
"      Supportive care to correct metabolic acidosis, hypoglycemia, respiratory failure, and anemia that may contribute to or be a consequence of heart failure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Once the patient is stabilized, surgical repair can be performed. The introduction of prostaglandin E1 (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40966?source=see_link\">",
"     alprostadil",
"    </a>",
"    ) has significantly decreased the mortality in neonates with critical coarctation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In addition, with the use of prostaglandin, it is rare for affected neonates to require emergency surgical repair or balloon angioplasty as a palliative emergency procedure. (See",
"    <a class=\"local\" href=\"#H3040001\">",
"     'Neonates and young infants'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Indications for intervention for noncritical presentation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H71184637\">",
"    <span class=\"h3\">",
"     Adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;The unoperated mean survival rate of adults with coarctation of the aorta is 35 years of age, with a mortality rate of 75 percent by 46 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3\">",
"     3",
"    </a>",
"    ]. Systemic hypertension, accelerated coronary heart disease, stroke, aortic dissection, and heart failure are common complications in adults who have not undergone correction for their coarctation or were operated later in life. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical manifestations and diagnosis of coarctation of the aorta\", section on 'Adults'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In 2008, the American College of Cardiology and American Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    guidelines for adults with congenital heart disease recommended intervention for coarctation for the following indications [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Peak to peak coarctation gradient &ge;20 mmHg. The peak to peak gradient is a measurement derived from catheterization data in which the peak pressure beyond the coarctation is subtracted from the peak pressure proximal to the coarctation.",
"     </li>",
"     <li>",
"      Peak to peak coarctation gradient &lt;20 mmHg with anatomic imaging evidence of significant coarctation and radiologic evidence of significant collateral flow.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H76537944\">",
"    <span class=\"h3\">",
"     Children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for intervention in children include heart failure, a peak instantaneous pressure gradient across the coarctation &gt;20 mmHg,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiologic detection of collateral circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. The resting gradient alone may be an unreliable indicator of severity when there is significant collateral circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link&amp;anchor=H17#H17\">",
"     \"Clinical manifestations and diagnosis of coarctation of the aorta\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link&amp;anchor=H10#H10\">",
"     \"Clinical manifestations and diagnosis of coarctation of the aorta\", section on 'Older infants and children'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Timing of repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic hypertension, accelerated coronary heart disease, stroke, aortic dissection, and heart failure are common complications in adults who have not undergone correction for their coarctation or were operated later in life [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3\">",
"     3",
"    </a>",
"    ]. Coarctation repair after early childhood does not prevent persistence or late recurrence of systemic hypertension. As a result, correction of coarctation should be performed in infancy or early childhood to prevent the development of chronic systemic hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/7\">",
"     7",
"    </a>",
"    ]. If coarctation escapes early detection, repair should be performed at the time of subsequent diagnosis. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Systemic hypertension'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PROCEDURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Options for correction of native discrete coarctation of the aorta include surgery and percutaneous interventions that include balloon angioplasty",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    stent placement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The types of surgical repair of coarctation include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Resection with end-to-end anastomosis",
"     </li>",
"     <li>",
"      Subclavian flap aortoplasty in infants with long-segment coarctation",
"     </li>",
"     <li>",
"      A bypass graft across the area of coarctation when the distance to be bridged is too long for an end-to-end repair",
"     </li>",
"     <li>",
"      Prosthetic patch aortoplasty, which is avoided whenever possible because of the frequent occurrence of aortic aneurysm or rupture [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/8-11\">",
"       8-11",
"      </a>",
"      ] (see",
"      <a class=\"local\" href=\"#H16\">",
"       'Aortic aneurysm, dissection, and rupture'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Perioperative mortality including neonates and young infants is rare (usually less than 1 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3,12\">",
"     3,12",
"    </a>",
"    ]. Survival rate was reported to be 98 percent at a median follow-up of 4.8 years of age for infants who were surgically repaired from 1996 to 2006 [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/12\">",
"     12",
"    </a>",
"    ]. Surgical repair is possible in preterm infants with birth weights less than 2.5 kg with an overall survival rate of 76 percent one year after initial repair [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Early morbidity includes postoperative paradoxical hypertension, left recurrent laryngeal nerve paralysis, phrenic nerve injury, and subclavian steal [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3\">",
"     3",
"    </a>",
"    ]. The latter should be suspected in patients with neurologic symptoms and reduced perfusion in the left arm because of compromise of the orifice of the left subclavian artery after subclavian flap angioplasty [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/14\">",
"     14",
"    </a>",
"    ]. Paraplegia due to spinal cord ischemia and mesenteric arteritis with bowel infarction are rare complications.",
"   </p>",
"   <p>",
"    Rebound hypertension (mean increase as high as 35 mmHg) is due initially to an increase in circulating catecholamines and may be accentuated by activation of the renin-angiotensin system [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. These responses are less common after balloon angioplasty [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/16\">",
"     16",
"    </a>",
"    ]. Postoperative increase in blood pressure may be prevented or blunted by perioperative administration of antihypertensive agents such as Nipride and a beta blocker in both adult and pediatric patients [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3,17-19\">",
"     3,17-19",
"    </a>",
"    ]. In addition, many patients remain hypertensive and require an oral antihypertensive agent(s) at discharge as discussed below [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Systemic hypertension'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Recoarctation is an important long-term complication especially in neonates and young infants in whom the risk of reintervention is between 5 and 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/12,13,20\">",
"     12,13,20",
"    </a>",
"    ]. The rate appears to be similar with the different surgical techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/21\">",
"     21",
"    </a>",
"    ]. Recurrence is usually due to inadequate aortic wall growth at the site of repair when surgery is performed before the aorta has reached adult size. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Recoarctation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Balloon angioplasty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Balloon angioplasty is a noninvasive alternative to surgical repair for older infants (greater than four months of age) and young children with native discrete coarctation. It remains the preferred intervention for all patients with isolated recoarctation regardless of age [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3,22,23\">",
"     3,22,23",
"    </a>",
"    ]. However, stent placement has replaced balloon angioplasty as the procedure of choice in older children and adults with native coarctation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4015728\">",
"    <span class=\"h3\">",
"     Native coarctation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Balloon angioplasty has been successfully performed in both children and adults with discrete native coarctation. This was illustrated in a large multicenter retrospective study that included 422 angioplasty procedures for native aortic coarctation in patients with a median age of 4.2 years (range 2 days to 63 years) from 1982 to 1995 [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/24\">",
"     24",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There were three deaths, all of them occurring in critically ill infants (ie, 9 days, 6 months, and 13 months).",
"     </li>",
"     <li>",
"      In 80 procedures (19 percent), an acute outcome was deemed suboptimal (defined as the presence of one or more of the following: residual peak to peak systolic pressure gradient &ge;20 mmHg, residual ratio of proximal to distal peak systolic pressure &ge;1.33 or a major complication, including death, aortic tear, or stroke). The risk of a suboptimal outcome was lower in institutions that performed more than 100 angioplastic procedures for both recurrent and native coarctation.",
"     </li>",
"     <li>",
"      Over the duration of the study period, balloon angioplasty was increasingly used in the treatment of native coarctation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Balloon angioplasty for native coarctation has been performed safely and successfully in infants between one and six months of age with discrete narrowing and no evidence of arch hypoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/22\">",
"     22",
"    </a>",
"    ]. However, balloon angioplasty is not as successful in infants with arch hypoplasia, which is commonly seen in neonatal and infantile aortic coarctation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. In addition, recoarctation occurs in most neonates after balloon angioplasty, even those with an initial good result, requiring further intervention generally within 5 to 12 weeks following the initial procedure. As a result, balloon angioplasty is",
"    <strong>",
"     not",
"    </strong>",
"    recommended for infants less than four months of age with aortic coarctation, especially if the lesion is accompanied by arch hypoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Palliative balloon angioplasty, however, may be considered in critically ill patients (irrespective of age) who have heart failure due to severe ventricular dysfunction, mitral regurgitation, or low cardiac output, or with systemic disease that is affected by cardiac function [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Critical coarctation in infancy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Although balloon angioplasty was the treatment of choice for discrete native coarctation in adults, most centers currently perform stent implantation for older children and adults with native discrete or long segment coarctation. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Stent placement'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Potential complications of balloon angioplasty and their frequency include [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/5,27-36\">",
"     5,27-36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Immediate residual pressure gradients &ge;20 mmHg (20 percent)",
"     </li>",
"     <li>",
"      Recoarctation (5 to 25 percent) (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Recoarctation'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Aneurysm formation (5 to 7 percent), and rarely aortic dissection and rupture (see",
"      <a class=\"local\" href=\"#H16\">",
"       'Aortic aneurysm, dissection, and rupture'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Femoral arterial complications, including occlusion (up to 15 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h4\">",
"     Balloon angioplasty versus surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies have shown that balloon angioplasty and surgical correction are equally effective in reducing the peak systolic pressure gradient early after intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/32,37,38\">",
"     32,37,38",
"    </a>",
"    ]. However, the risks of recoarctation and aneurysm formation were greater in patients who undergo balloon angioplasty compared with those who were surgically repaired.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4016665\">",
"    <span class=\"h3\">",
"     Recoarctation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recoarctation is a common complication following either surgical or balloon angioplasty, particularly in infants and young children. Guidelines from a number of professional societies have recommended balloon angioplasty with or without stenting as the preferred intervention of patients with isolated recoarctation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3,22,23\">",
"     3,22,23",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Recoarctation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Stent placement",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children and adults, stent placement after balloon angioplasty reduces the complications associated with angioplasty or surgery, results in a minimal residual gradient, improves luminal diameter, and sustains hemodynamic benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/39-43\">",
"     39-43",
"    </a>",
"    ]. Patients in whom a stent is placed are more likely to require a planned reintervention. In children, the stent needs to be dilated as the child grows.",
"   </p>",
"   <p>",
"    Data from a large multi-center case series of over 500 patients from 1989 to 2005, who were over the age of four years (median age 15 years), demonstrated the efficacy and relative safety of stent placement for both native and recurrent coarctation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. In this cohort, the stent placement (which was predominantly bare metal) was successful in 98 percent of cases defined as reduction in the gradient to &lt;20 mmHg or a ratio of post stent coarctation to descending aorta ratio &gt;0.8. Acute complications occurred in 14 percent of patients including two procedure-related deaths. In 41 of 160 procedures that had follow-up imaging (25 percent), aortic abnormalities were detected and included stent restenosis (n = 16), aneurysms (n = 13), and dissections (n = 5).",
"   </p>",
"   <p>",
"    Subsequently, the use of covered stents has been advocated because it appears they reduce the risk of aneurysms [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. These stents consist of a bare metal stent with a polytetrafluoroethylene sleeve. In the United States, commercially made covered stents are not approved by the Food and Drug Administration but are available for clinical use in Europe and other parts of the world. In the United States, covered stents are available in some centers conducting specific clinical trials and those that fashion individual covered stents [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stent placement is",
"    <strong>",
"     NOT",
"    </strong>",
"    generally recommended in patients less than 25 kg due to potential injury to the femoral artery from the relatively large sheath required for stent delivery. In addition, the aorta in patients less than 25 kg is small. Although stents have been successfully placed in patients less than 30 kg, implanting a stent in such patients will commit them for repeated interventions to expand the stent as they grow [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. The risks associated with repeat transcatheter interventions need to be balanced against the more invasive surgical repair.",
"   </p>",
"   <p>",
"    In our practice, we will only consider stent placement in patients who are larger enough to receive a stent that can be expanded to an adult size [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3039992\">",
"     'Our management approach for native coarctation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     MANAGEMENT APPROACH",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3039949\">",
"    <span class=\"h2\">",
"     Societal guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management guidelines have been developed based on review of the available literature by the American Heart Association (AHA), American College of Cardiology (ACC), and the Canadian Cardiovascular Society for adult and pediatric patients with congenital heart disease including coarctation of the aorta [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3,22,23\">",
"     3,22,23",
"    </a>",
"    ]. All three published guidelines recommend that correction of coarctation should be performed as early as possible (optimally early in childhood) to reduce the long-term morbidity and improve survival, and corrective surgery and percutaneous interventions are acceptable options for coarctation repair. The choice of intervention should be determined by consultation with clinicians (ie, cardiologist, interventionists, and surgeons) experienced in treating patients with congenital heart disease and is dependent on the underlying morphology, age of the patient, and the presence or absence of other cardiac lesions. Of note, all three guidelines observed that balloon angioplasty with and without stenting has increasingly been performed as both technology and the expertise of interventionists has improved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3039992\">",
"    <span class=\"h2\">",
"     Our management approach for native coarctation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Corrective intervention (ie, surgery or transcatheter intervention) should be performed in all patients with coarctation with either peak-to-peak (or maximum instantaneous) coarctation gradient &ge;20 mmHg, OR peak-to-peak coarctation gradient &lt;20 mmHg in the presence of anatomic imaging evidence of significant coarctation with radiologic evidence of significant collateral flow. Our management approach is based on the age of the patient and is consistent with the pediatric AHA guidelines, and the",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    adult guidelines for the management of native and recurrent coarctation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3,22\">",
"     3,22",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Overview'",
"    </a>",
"    above.).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3040001\">",
"    <span class=\"h3\">",
"     Neonates and young infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;In neonates with critical coarctation, an infusion with prostaglandin E1 (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40966?source=see_link\">",
"     alprostadil",
"    </a>",
"    ) to maintain patency of the ductus arteriosus should be administered until corrective surgery can be performed. In our centers, we generally start with a dose of 0.025 to 0.05",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute and increase as needed to a maximum dose of 0.1",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute. For patients with heart failure, administration of inotropic agents and general supportive care (eg, intubation, correction of metabolic acidosis, and mechanical ventilation for respiratory failure) should also be given. Palliative balloon angioplasty may be considered to stabilize a critically ill patient [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Critical coarctation in infancy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Once the patient is stabilized, surgical correction is recommended as it is associated with a lower risk for reintervention compared with balloon angioplasty. (See",
"    <a class=\"local\" href=\"#H4015728\">",
"     'Native coarctation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3040038\">",
"    <span class=\"h3\">",
"     Older infants and young children",
"    </span>",
"    &nbsp;&mdash;&nbsp;For younger pediatric patients, surgical correction has been the primary treatment of native coarctation at most centers; however, there has been an increased use of balloon angioplasty as noted by the 2011 AHA pediatric guidelines for transcatheter intervention for congenital heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/22\">",
"     22",
"    </a>",
"    ]. The decision between balloon angioplasty versus surgical repair is determined by the expertise of the tertiary center and the underlying morphology of the coarctation.",
"   </p>",
"   <p>",
"    Our approach is consistent with the 2011 AHA pediatric guidelines as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In infants and children between four months and five years of age (ie, weight below 25 kg), we prefer balloon angioplasty if the lesion is discrete and there is no evidence of arch hypoplasia [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In patients with complex coarctation anatomy or systemic disease (eg, Turner syndrome), the decision to use balloon angioplasty versus surgical repair is made on a case-by-case basis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3040169\">",
"    <span class=\"h3\">",
"     Older children and adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;For larger patients (weight &gt;25 kg), transcatheter intervention with stenting has become the preferred intervention in many tertiary centers including our own institutions. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Stent placement'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In older children, we perform stent placement if the stent can be expanded to an adult size in the following settings [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Coarctation gradient &gt;20 mmHg including those that are long-segment lesions (ie, &gt;10 to 15 mm in length)",
"     </li>",
"     <li>",
"      Coarctation gradient of &lt;20 mmHg but with systemic hypertension due to coarctation of the aorta or radiologic evidence of significant collateral flow",
"     </li>",
"     <li>",
"      Failed balloon angioplasty procedure due to vessel recoil",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Stenting may be less successful in patients with suboptimal anatomy with vessel tortuosity and transverse arch hypoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/23\">",
"     23",
"    </a>",
"    ]. For these patients, the decision to perform stent placement versus surgical correction must be made on a case-by-case decision by the clinical team.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     LONG-TERM CARDIOVASCULAR OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Major long-term complications following repair include recoarctation, aortic aneurysm, and systemic hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Recoarctation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent coarctation refers to restenosis after an initially successful dilatation or operative repair. The major findings that suggest recurrent stenosis are resting hypertension and headaches (not usually found in children). In asymptomatic patients (4 of 22 in one review), the diagnosis is made by screening imaging studies [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rate of recoarctation is approximately 5 to 14 percent after surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/12,13,20\">",
"     12,13,20",
"    </a>",
"    ]. It is seen primarily in children usually due to inadequate aortic wall growth at the site of repair when surgery is performed before the aorta has reached adult size.",
"   </p>",
"   <p>",
"    Children are also at greater risk for recoarctation compared with adults following balloon angioplasty.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one case series of 93 patients (median age 4.6 years, range 3 days to 29 years) with an initial successful result after balloon angioplasty, restenosis occurred in 21 patients (23 percent) with reintervention in 18 [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast, there was no restenosis in 49 patients (mean age 22 years, range 15 to 55 years) who were treated successfully with balloon angioplasty [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/27\">",
"       27",
"      </a>",
"      ]. However, in another cohort of 87 adolescent and adult patients, six patients (7 percent) developed restenosis that required intervention [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Higher rates of recoarctation occur in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Neonates (&lt;30 days of age) and to a lesser extent older infants (&lt;1 year of age) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/21,28,52-57\">",
"       21,28,52-57",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      When the coarctation segment is &lt;3.5 mm before dilation or &lt;6 mm after angioplasty [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/54\">",
"       54",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Patients with isthmus hypoplasia [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/28,54\">",
"       28,54",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Management of recoarctation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3040617\">",
"    <span class=\"h4\">",
"     Indications for intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for intervention for recoarctation include hypertension, a peak instantaneous pressure gradient across the coarctation &ge;20 mmHg,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    collateral circulation on MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3,4,22\">",
"     3,4,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3041716\">",
"    <span class=\"h4\">",
"     Percutaneous intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consistent with the 2008",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    adult and the 2011 AHA pediatric guidelines, percutaneous catheter intervention is our preferred treatment of choice [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3,22\">",
"     3,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several studies have shown successful repair of discrete recoarctation using percutaneous balloon angioplasty, usually with stenting in the older child and adult [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/6,58-64\">",
"     6,58-64",
"    </a>",
"    ]. Mortality for surgical reoperation is higher than for primary repair (1 to 3 percent versus less than 1 percent) and can be as high as 5 to 10 percent if there are significant comorbidities or left ventricular dysfunction. For these reasons, catheter based intervention is recommended to treat discrete recoarctation. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Stent placement'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Surgical repair by a surgeon with training and expertise in congenital heart disease is indicated for recoarctation, if confounding features are present such as long recoarctation segment, hypoplasia of the aortic arch, or aortic aneurysm or pseudoaneurysm [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Aortic aneurysm, dissection, and rupture'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Aortic aneurysm, dissection, and rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;An aortic aneurysm may develop following surgery, balloon dilatation or stent implantation of native coarctation, especially after patch angioplasty [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/8-11,65,66\">",
"     8-11,65,66",
"    </a>",
"    ]. Aneurysms typically occur at the site of previous repair. The reported incidence of aortic aneurysm after surgical repair or balloon angioplasty for coarctation varies widely [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/10,11,27,66\">",
"     10,11,27,66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of 65 patients who underwent surgery, an aneurysm at the repair site was detected by magnetic resonance imaging in 3 of 14 patients treated with patch angioplasty compared with no patients of the 51 who were treated with resection and end-to-end anastomosis, or a subclavian flap procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another report, 891 patients were evaluated 1 to 24 years after coarctation repair, 48 patients (5.3 percent) developed aneurysms. However, most of the patients were treated with patch angioplasty (n = 43), and only four patients were treated with end-to-end anastomosis and one patient with a prosthetic graft replacement [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In one retrospective series of 58 adult and adolescent patients (mean age 24 years), 8 percent of patients developed aneurysms (8 percent) one year after balloon angioplasty [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/27\">",
"       27",
"      </a>",
"      ]. However, in another series of 29 patients (age range 15 to 71 years), there was no aneurysm formation noted at a mean follow-up of 8.5 years [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/67\">",
"       67",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Aneurysm formation occurs at and around the coarctation site due to an inherent medial abnormality, which is characterized by fragmentation of elastic fibers, an increase in ground substance, and a reduction in the number of smooth muscle cells [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/68\">",
"     68",
"    </a>",
"    ]. Proposed mechanisms for developing aortic aneurysm",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dissection after coarctation repair include failure of surgical repair to remove abnormal tissue or damage from balloon angioplasty [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. In addition, an abnormal aortic root above a coexisting bicuspid aortic valve may predispose to ascending aortic aneurysm formation or dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=see_link\">",
"     \"Clinical manifestations and diagnosis of bicuspid aortic valve\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Risk factors for post-repair aneurysms are age at the time of coarctation repair (&ge;13.5 years) and the use of patch angioplasty [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/10,66,73\">",
"     10,66,73",
"    </a>",
"    ]. The risk of dissection is increased during pregnancy, which is associated with hemodynamic and physiologic changes superimposed on the preexisting aortic medial changes. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Pregnancy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Aortic aneurysm or pseudoaneurysm is generally treated surgically. Alternatively, endovascular stent grafts have been used to repair aortic aneurysms after coarctation repair. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/54/25449?source=see_link&amp;anchor=H11#H11\">",
"     \"Management of aortic dissection\", section on 'Endovascular stent-grafts'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/23/37240?source=see_link\">",
"     \"Thoracic endovascular aneurysm repair\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one case series of six adult patients (age range 31 to 68 years), placement of a stent graft was successful in all cases with no related morbidity or mortality at one year follow-up after intervention [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/74\">",
"       74",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a second case series of nine patients, endovascular stenting was successfully performed without any major complications at a mean follow-up of 24 months [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/75\">",
"       75",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Systemic hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic hypertension is one of the major long-term problems following repair of coarctation of the aorta. Although the blood pressure typically falls after successful repair, persistent or recurrent hypertension and disproportionate systolic hypertension with exercise are observed especially in patients whose repair is performed later in life.",
"   </p>",
"   <p>",
"    Hypertension and left ventricular hypertrophy are among the factors that contribute to premature death from coronary and cerebrovascular disease in patients with a surgically repaired coarctation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/76\">",
"     76",
"    </a>",
"    ]. As a result, it is important to control elevated blood pressure. As noted in the 2008",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    adult congenital heart disease guidelines, hypertension should be controlled by beta blockers, ACE inhibitors, or angiotensin receptor blockers [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3\">",
"     3",
"    </a>",
"    ]. The choice of agents may be influenced by the aortic root size and the presence of aortic regurgitation. In patients with resistant systemic hypertension, a combination of drugs from both classes is required to effectively control blood pressure. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Long-term survival'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27626?source=see_link&amp;anchor=H15#H15\">",
"     \"Treatment of hypertension in children and adolescents\", section on 'Antihypertensive drugs'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32330?source=see_link&amp;anchor=H28#H28\">",
"     \"Overview of hypertension in adults\", section on 'Drug treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27626?source=see_link&amp;anchor=H13#H13\">",
"     \"Treatment of hypertension in children and adolescents\", section on 'Pharmacologic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hypertension is more common in patients whose repair was performed after 20 years of age compared with those who were corrected in early childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/27,77-79\">",
"     27,77-79",
"    </a>",
"    ]. In a review of patients undergoing surgical repair during childhood, blood pressure was normal in 90 percent of patients at five year follow-up, and fell to 50 and 25 percent at 20 and 25 years post-correction [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/78\">",
"     78",
"    </a>",
"    ]. In contrast, when repair was performed in early adulthood (mean age 22 years), hypertension persisted in 37 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/27\">",
"     27",
"    </a>",
"    ], and in patients after age 40, approximately 50 percent remained hypertensive. In addition, normotensive patients, especially those repaired at an older age, often have an exaggerated rise in systolic pressure in response to exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/78,80,81\">",
"     78,80,81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The factors responsible for the persistent risk of hypertension after coarctation repair are not well understood. Among the probable contributing factors are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Structural and functional abnormalities that decrease compliance in the precoarctation arterial wall [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/82\">",
"       82",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased ventricular stiffness, left ventricular hypertrophy, and a hypercontractile state in postrepair patients [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/81,83\">",
"       81,83",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5018111\">",
"    <span class=\"h2\">",
"     Other cardiovascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite coarctation repair, individuals with aortic coarctation are at increased risk for coronary artery disease and stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/76,84,85\">",
"     76,84,85",
"    </a>",
"    ]. The increased prevalence of coronary artery disease appears to be caused by traditional cardiovascular (CV) risk factors as illustrated by a study of patients from the Quebec Congenital Heart Disease Database [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/84\">",
"     84",
"    </a>",
"    ]. Rates of coronary artery disease, heart failure, stroke, peripheral vascular disease, hypertension, and hyperlipidemia were higher in 756 individuals with aortic coarctation (repaired or unrepaired) compared to 6481 individuals with ventricular septal defect. Multivariate analysis demonstrated that the traditional CV risk factors of hypertension, hyperlipidemia, diabetes mellitus, male sex, and age independently predicted the development of coronary artery disease, whereas the diagnosis of coarctation did not. These findings highlight the importance of treating the associated cardiovascular risk factors (eg, hypertension and dyslipidemia) in patients with coarctation of the aorta to prevent late CV sequelae. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H76537619\">",
"    <span class=\"h1\">",
"     LONG-TERM MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H76537727\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with coarctation (repaired or not) should be monitored with lifelong congenital cardiology follow-up and imaging. Follow-up of adults should include evaluation by or consultation with a cardiologist with expertise in adult congenital heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3\">",
"     3",
"    </a>",
"    ]. Because coarctation of the aorta is associated with an increased risk of intracranial aneurysms (ie, berry aneurysms), cranial imaging with either magnetic resonance imaging (MRI) or computerized tomography (CT) should be performed in all patients with aortic coarctation to evaluate intracranial vessels.",
"   </p>",
"   <p>",
"    Patients who have undergone surgical or percutaneous intervention for coarctation should receive at least yearly clinical follow-up. Monitoring should include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Close observation for the appearance or reappearance of systemic hypertension at rest or with exercise. Hypertension should be treated aggressively, and recoarctation should be excluded.",
"     </li>",
"     <li>",
"      Imaging of the coarctation repair site by MRI or CT to detect long-term complications (eg, aneurysms and recoarctation) should be performed at intervals of five years or less depending on the specific anatomic findings before and after repair [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/86\">",
"       86",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Long-term cardiovascular outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The role of routine exercise testing for follow-up in adults is not well established; however, it should be performed in patients who wish to participate in competitive sports [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Competitive sports'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5687186\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice of imaging for routine follow-up differs between adults and children.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In infants and younger children, acoustic windows permit excellent echocardiographic imaging so that MRI or CT scan is not needed. Sedation is required for adequate imaging in young children who cannot adequately cooperate with MRI, and there is cumulative radiation exposure with CT scans.",
"      <br/>",
"      <br/>",
"      In children, we recommend echocardiographic assessment of the area of coarctation within six months from intervention or earlier based on clinical findings (eg, elevated blood pressure and weak femoral pulses). If the initial imaging is normal, echocardiography is performed on a yearly basis until they are old enough to cooperate for MRI imaging without the need for sedation",
"     </li>",
"     <li>",
"      In adults, MRI may be most cost-effective for detecting both recoarctation and aneurysm formation [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/87\">",
"       87",
"      </a>",
"      ], and avoids the cumulative radiation exposure of multiple CT scans.",
"      <br/>",
"      <br/>",
"      In adults, we recommend that a MRI be done one year after correction. If the initial post-operative MRI is normal, then follow-up MRI can be done every three to five years.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H76537865\">",
"    <span class=\"h2\">",
"     Endocarditis prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endocarditis prophylaxis is",
"    <strong>",
"     NOT",
"    </strong>",
"    required for patients with uncomplicated native coarctation or six months after successfully repaired native or uncomplicated recoarctation. Antibiotic prophylaxis is indicated in patients whose repair involved insertion of a conduit, or during the first six months after repair if prosthetic material or stent was used. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Physical activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data are lacking on the impact of exercise on patients with coarctation of the aorta. Recommendations have been developed by expert panels to provide guidance in this area.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Competitive sports",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiology consultation, exercise testing, and an echocardiogram are suggested before permitting low to moderate level dynamic sports or light weight lifting [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3\">",
"     3",
"    </a>",
"    ]. These data are used to determine the degree of exercise that is reasonable for the individual patient.",
"   </p>",
"   <p>",
"    We agree generally with the following recommendations of the 2005 36th Bethesda conference for athletes with coarctation of the aorta [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/88\">",
"     88",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_figure graphicRef64493 \" href=\"UTD.htm?28/51/29489\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Athletes with mild coarctation and without large collateral vessels or significant aortic root dilation (z-score 3.0 or less, score 3.0 = 3 standard deviations from the mean for patient size), a normal exercise test, a small pressure gradient at rest (usually 20 mmHg or less between upper and lower limbs), and a peak systolic blood pressure &le;230 mmHg with exercise can engage in all competitive sports.",
"     </li>",
"     <li>",
"      Athletes with a systolic",
"      <span class=\"nowrap\">",
"       arm/leg",
"      </span>",
"      gradient &gt;20 mmHg or exercise-induced hypertension with a systolic blood pressure greater than 230 mmHg can engage in only low-intensity competitive sports (class IA) until treated.",
"     </li>",
"     <li>",
"      Following surgical or percutaneous intervention, clinical evaluation should include chest x-ray, electrocardiogram, exercise testing, echocardiogram, and MRI.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For athletes with evidence of significant aortic dilation (z-score greater than 3.0), wall thinning, or aneurysm formation, participation should be restricted to low-intensity competitive sports (classes IA and IB).",
"     </li>",
"     <li>",
"      During the first two months following surgery, athletes should refrain from high-intensity static exercise (classes IIIA, IIIB, and IIIC) and sports that pose the danger of bodily collision.",
"     </li>",
"     <li>",
"      Participation in competitive sports two or more months after surgical or balloon angioplasty for coarctation of the aorta is permitted for asymptomatic patients with a systolic",
"      <span class=\"nowrap\">",
"       arm/leg",
"      </span>",
"      blood pressure gradient &le; 20 mmHg at rest and a normal peak systolic blood pressure during rest and exercise. All sports are permissible except those with a large static component (particularly, classes IIIA, IIIB, and IIIC).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Guidelines for patients with bicuspid aortic valve with or without aortic root dilation are discussed separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7078?source=see_link\">",
"     \"Treatment of bicuspid aortic valve stenosis in adults\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Recreational sports",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, the recommendation for the level of sport participation is dependent on the clinical status of the patients as assessed by echocardiography, and blood pressure measurements in the upper and lower extremities. If the level of activity is comparable to that required by competitive athletes, an exercise stress test is performed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with normal blood pressure, no residual coarctation, and normal ascending aorta diameter can participate in all activities without restriction (ie, normal life activity).",
"     </li>",
"     <li>",
"      Patients with residual coarctation or a dilated ascending aorta are managed on a case-by-case scenario. The degree of narrowing and dilatation of the ascending aorta dictates the level of sport activity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coarctation of the aorta and associated lesions, particularly bicuspid aortic valve, aortic stenosis, and aortic root dilation should be evaluated before pregnancy for appropriate counseling and advice [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Unrepaired coarctation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Major complications associated with unoperated aortic coarctation during pregnancy are uncommon but can be fatal [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/89\">",
"     89",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pregnancy increases the risk of aortic rupture or dissection at the site of narrowing or in the aortic root in patients with a coexisting bicuspid aortic valve. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/25/27032?source=see_link\">",
"       \"Pregnancy in women with a bicuspid aortic valve\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Intracranial hemorrhage can occur, but hypertension is not a necessary precondition.",
"     </li>",
"     <li>",
"      Left ventricular failure is uncommon despite the increased volume load of pregnancy imposed on the already pressure-loaded left ventricle [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/90\">",
"       90",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Women who present with an unrepaired coarctation during pregnancy should have a careful assessment of the adequacy of blood pressure control. We allow women who are normotensive to carry the pregnancy to term and pursue repair of the coarctation a few weeks after delivery.",
"   </p>",
"   <p>",
"    In contrast, if the blood pressure is not well controlled during pregnancy, intervention is recommended. Both surgery and stent placement during pregnancy to alleviate obstruction should be considered by a multispecialty team. For stent placement, potential teratogenic exposure from radiation can be limited by performing the procedure after the second trimester with abdominal shielding. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Stent placement'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Repaired coarctation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most women with successful coarctation repair have an uncomplicated pregnancy, although the rate of miscarriage [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/89,91,92\">",
"     89,91,92",
"    </a>",
"    ] and preeclampsia are higher than in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Pregnancy outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A literature review of studies published between 1985 and 2007 found the following rates of complications during pregnancies (&gt;20 weeks gestation) among women with coarctation of the aorta (combined repaired and unrepaired) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/93\">",
"     93",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With respect to the mother, cardiac complications were uncommon. Arrhythmia occurred in no pregnancies, heart failure in 3 of 303 pregnancies (1 percent), and cardiovascular events (myocardial infarction, stroke, and cardiovascular mortality) in 1 of 304 pregnancies (0.3 percent).",
"     </li>",
"     <li>",
"      Preeclampsia was reported in 12 of 245 pregnancies (4.9 percent as compared to an expected rate of 2 to 3 percent). Pregnancy-induced hypertension was reported in 27 of 244 (11.1 percent as compared with an expected rate of 5 percent).",
"     </li>",
"     <li>",
"      With respect to the fetus, premature delivery occurred in 20 of 253 pregnancies (7.9 percent), no fetal mortality in 254 pregnancies, perinatal mortality in 6 of 254 pregnancies (2.4 percent), and congenital heart disease (of any type) in the offspring in 10 of 251 pregnancies (4 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Outcomes limited to women who had undergone coarctation repair were reported in a retrospective study of 54 women with 126 pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/92\">",
"     92",
"    </a>",
"    ]. There were 98 successful pregnancies, 22 miscarriages, and 6 abortions. During pregnancy and delivery, there were no serious cardiovascular complications. Hypertension alone was reported in 21 pregnancies in 14 women, and preeclampsia in 5 pregnancies in 4 women. Five of eight patients who had serial echocardiographic assessment had an increase in gradient &ge;15 mmHg.",
"   </p>",
"   <p>",
"    In another study, serious complications were uncommon in women with a hemodynamically significant gradient (&ge;20 mmHg) after repair [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/89\">",
"     89",
"    </a>",
"    ]. These women were more likely to have systemic hypertension related to the increased coarctation gradient. However, there are case reports of aortic rupture or dissection that occur with pregnancy after coarctation repair due to the hemodynamic and aortic medial changes of pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/94\">",
"     94",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     LONG-TERM SURVIVAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The largest single center series describing long-term outcome included 571 patients who underwent isolated operative repair of coarctation at the Mayo Clinic between 1946 and 1981 [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/76\">",
"     76",
"    </a>",
"    ]. The survival rates were 91, 84, and 72 percent at age 10, 20, and 30 years, respectively. The most common cause of late death was coronary artery disease, followed by sudden death, heart failure, cerebrovascular accident, and ruptured aortic aneurysm.",
"   </p>",
"   <p>",
"    Subsequent reports demonstrate improved survival rates.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Data from the United Kingdom Northern Congenital Abnormality survey of children born between 1985 and 2003 demonstrated an estimated 20-year survival rate of 90 percent for patients with coarctation of the aorta [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/95\">",
"       95",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A report from the European Heart Survey on adult congenital heart disease described 551 patients with coarctation; 90 percent had a previous repair with a mean age of 26 years at the beginning of the study period [",
"      <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/96\">",
"       96",
"      </a>",
"      ]. At the end of the study, the five-year mortality rate was 0.7 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Survival in the Mayo Clinic series was best in patients operated before age 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/76\">",
"     76",
"    </a>",
"    ]. The importance of age at the time of repair on survival has been noted in other studies [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/78,79,97\">",
"     78,79,97",
"    </a>",
"    ]. When surgery is performed before age 20 years of age, 20-year survival is only slightly less than controls (95 versus 97 percent in one series) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/79\">",
"     79",
"    </a>",
"    ]. In contrast, when surgery is performed between the ages of 20 and 40, 25-year survival is approximately 75 percent, and those repaired after age 40 have a 15-year survival of only 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?20/27/20922/abstract/97\">",
"     97",
"    </a>",
"    ]. Similar data on long-term survival after balloon angioplasty are not available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/43/41649?source=see_link\">",
"       \"Patient information: Aortic coarctation in adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/47/25329?source=see_link\">",
"       \"Patient information: Aortic coarctation in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend corrective intervention for all patients with coarctation who fulfill one of the following criterion (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H26\">",
"       'Long-term survival'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Neonates who present with critical coarctation that is dependent on ductal patency for survival.",
"     </li>",
"     <li>",
"      Older patients with coarctation with peak-to-peak (or maximum instantaneous) gradient &ge;20 mmHg",
"      <strong>",
"       OR",
"      </strong>",
"      a gradient &lt;20 mmHg with anatomic imaging evidence of significant coarctation and collateral flow.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgery and balloon angioplasty are both reasonable options to correct discrete coarctation and should be performed in early childhood for optimal results and survival. In our centers, the following approach for repair of discrete aortic coarctation is based on the age of the patient and the morphology of the underlying lesion (see",
"      <a class=\"local\" href=\"#H3039992\">",
"       'Our management approach for native coarctation'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Infants younger than four months of age &ndash; We recommend surgical correction in infants with coarctation of the aorta who are below four months of age (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). In neonates, we recommend initial administration of a continuous infusion of prostaglandin E1 (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40966?source=see_link\">",
"       alprostadil",
"      </a>",
"      ) to maintain ductal patency and stabilize the patient prior to surgical repair (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3040001\">",
"       'Neonates and young infants'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants and children between four months to five years of age &ndash; The decision regarding balloon angioplasty versus surgical repair is determined by the expertise of the center and the underlying morphology of the coarctation. In our center, balloon angioplasty is the preferred procedure if the lesion is discrete and there is no evidence of arch hypoplasia. However, surgical repair continues to be the preferred approach in many centers all over the world for younger than 5 years of age. In patients with complex coarctation anatomy or systemic disease, the decision to perform balloon angioplasty versus surgical repair is made on a case-by-case basis by the clinical team.",
"     </li>",
"     <li>",
"      Children older than five years of age to adults &ndash; If the patient is large enough so that a stent that can be expanded to an adult size is used, we suggest transcatheter intervention with stent placement for discrete coarctation of the aorta (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). For patients with suboptimal anatomy, the decision to perform stent placement versus surgical correction is made on a case-by-case basis by the clinical team.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complications following either surgery or balloon angioplasty include recoarctation, aortic aneurysm, and dissection, and systemic hypertension. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Long-term cardiovascular outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest catheter intervention (ie, balloon angioplasty with or without stent placement) to correct coarctation in patients with a peak-to-peak gradient of at least 20 mmHg (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Surgical repair of recoarctation is indicated if confounding features (eg, long coarctation segment or concomitant hypoplasia of the aortic arch) are present. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Management of recoarctation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with either uncorrected or corrected aortic coarctation should receive regular cardiovascular follow-up including blood pressure monitoring.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Cranial imaging is recommended in patients with coarctation of the aorta to evaluate intracranial vessels as they are at-risk for intracranial aneurysms. (See",
"      <a class=\"local\" href=\"#H76537727\">",
"       'Monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who have a corrected lesion, evaluation includes periodic aortic imaging to detect potential postrepair complications such as recoarctation or aneurysm. In addition, when hypertension is present, it should be treated aggressively, and the presence of recoarctation should be excluded by imaging studies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although data are lacking, expert panel recommendations are used to guide patients with coarctation regarding participation in competitive sports and physical activity. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Physical activity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pregnancy increases the risk of aneurysm, dissection, and intracerebral hemorrhage both in women who have undergone correction and those who have not. In addition, the risk of preeclampsia, premature birth, and maternal hypertension is greater in pregnant women with coarctation compared with the general obstetrical population. Intervention may be necessary in pregnant women with poorly controlled blood pressure. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Pregnancy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/1\">",
"      Leoni F, Huhta JC, Douglas J, et al. Effect of prostaglandin on early surgical mortality in obstructive lesions of the systemic circulation. Br Heart J 1984; 52:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/2\">",
"      Korbmacher B, Krogmann ON, Rammos S, et al. Repair of critical aortic coarctation in neonatal age. J Cardiovasc Surg (Torino) 2002; 43:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/3\">",
"      Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 2008; 118:e714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/4\">",
"      Attenhofer Jost CH, Schaff HV, Connolly HM, et al. Spectrum of reoperations after repair of aortic coarctation: importance of an individualized approach because of coexistent cardiovascular disease. Mayo Clin Proc 2002; 77:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/5\">",
"      Rao PS, Galal O, Smith PA, Wilson AD. Five- to nine-year follow-up results of balloon angioplasty of native aortic coarctation in infants and children. J Am Coll Cardiol 1996; 27:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/6\">",
"      Yetman AT, Nykanen D, McCrindle BW, et al. Balloon angioplasty of recurrent coarctation: a 12-year review. J Am Coll Cardiol 1997; 30:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/7\">",
"      Seirafi PA, Warner KG, Geggel RL, et al. Repair of coarctation of the aorta during infancy minimizes the risk of late hypertension. Ann Thorac Surg 1998; 66:1378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/8\">",
"      Mendelsohn AM, Crowley DC, Lindauer A, Beekman RH 3rd. Rapid progression of aortic aneurysms after patch aortoplasty repair of coarctation of the aorta. J Am Coll Cardiol 1992; 20:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/9\">",
"      Parks WJ, Ngo TD, Plauth WH Jr, et al. Incidence of aneurysm formation after Dacron patch aortoplasty repair for coarctation of the aorta: long-term results and assessment utilizing magnetic resonance angiography with three-dimensional surface rendering. J Am Coll Cardiol 1995; 26:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/10\">",
"      Parikh SR, Hurwitz RA, Hubbard JE, et al. Preoperative and postoperative \"aneurysm\" associated with coarctation of the aorta. J Am Coll Cardiol 1991; 17:1367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/11\">",
"      Knyshov GV, Sitar LL, Glagola MD, Atamanyuk MY. Aortic aneurysms at the site of the repair of coarctation of the aorta: a review of 48 patients. Ann Thorac Surg 1996; 61:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/12\">",
"      Burch PT, Cowley CG, Holubkov R, et al. Coarctation repair in neonates and young infants: is small size or low weight still a risk factor? J Thorac Cardiovasc Surg 2009; 138:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/13\">",
"      Karamlou T, Bernasconi A, Jaeggi E, et al. Factors associated with arch reintervention and growth of the aortic arch after coarctation repair in neonates weighing less than 2.5 kg. J Thorac Cardiovasc Surg 2009; 137:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/14\">",
"      Saalouke MG, Perry LW, Breckbill DL, et al. Cerebrovascular abnormalities in postoperative coarctation of aorta. Four cases demonstrating left subclavian steal on aortography. Am J Cardiol 1978; 42:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/15\">",
"      Rocchini AP, Rosenthal A, Barger AC, et al. Pathogenesis of paradoxical hypertension after coarctation resection. Circulation 1976; 54:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/16\">",
"      Choy M, Rocchini AP, Beekman RH, et al. Paradoxical hypertension after repair of coarctation of the aorta in children: balloon angioplasty versus surgical repair. Circulation 1987; 75:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/17\">",
"      Moltzer E, Mattace Raso FU, Karamermer Y, et al. Comparison of Candesartan versus Metoprolol for treatment of systemic hypertension after repaired aortic coarctation. Am J Cardiol 2010; 105:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/18\">",
"      Tabbutt S, Nicolson SC, Adamson PC, et al. The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial. J Thorac Cardiovasc Surg 2008; 136:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/19\">",
"      Tabbutt S, Nicolson SC, Dominguez TE, et al. Perioperative course in 118 infants and children undergoing coarctation repair via a thoracotomy: a prospective, multicenter experience. J Thorac Cardiovasc Surg 2008; 136:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/20\">",
"      Kaushal S, Backer CL, Patel JN, et al. Coarctation of the aorta: midterm outcomes of resection with extended end-to-end anastomosis. Ann Thorac Surg 2009; 88:1932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/21\">",
"      Beekman RH, Rocchini AP, Behrendt DM, et al. Long-term outcome after repair of coarctation in infancy: subclavian angioplasty does not reduce the need for reoperation. J Am Coll Cardiol 1986; 8:1406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/22\">",
"      Feltes TF, Bacha E, Beekman RH 3rd, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation 2011; 123:2607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/23\">",
"      Silversides CK, Kiess M, Beauchesne L, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome. Can J Cardiol 2010; 26:e80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/24\">",
"      McCrindle BW, Jones TK, Morrow WR, et al. Acute results of balloon angioplasty of native coarctation versus recurrent aortic obstruction are equivalent. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators. J Am Coll Cardiol 1996; 28:1810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/25\">",
"      Redington AN, Booth P, Shore DF, Rigby ML. Primary balloon dilatation of coarctation of the aorta in neonates. Br Heart J 1990; 64:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/26\">",
"      Patel HT, Madani A, Paris YM, et al. Balloon angioplasty of native coarctation of the aorta in infants and neonates: is it worth the hassle? Pediatr Cardiol 2001; 22:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/27\">",
"      Fawzy ME, Fathala A, Osman A, et al. Twenty-two years of follow-up results of balloon angioplasty for discreet native coarctation of the aorta in adolescents and adults. Am Heart J 2008; 156:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/28\">",
"      Fletcher SE, Nihill MR, Grifka RG, et al. Balloon angioplasty of native coarctation of the aorta: midterm follow-up and prognostic factors. J Am Coll Cardiol 1995; 25:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/29\">",
"      Erbel R, Bednarczyk I, Pop T, et al. Detection of dissection of the aortic intima and media after angioplasty of coarctation of the aorta. An angiographic, computer tomographic, and echocardiographic comparative study. Circulation 1990; 81:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/30\">",
"      Tynan M, Finley JP, Fontes V, et al. Balloon angioplasty for the treatment of native coarctation: results of Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol 1990; 65:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/31\">",
"      Cooper RS, Ritter SB, Rothe WB, et al. Angioplasty for coarctation of the aorta: long-term results. Circulation 1987; 75:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/32\">",
"      Shaddy RE, Boucek MM, Sturtevant JE, et al. Comparison of angioplasty and surgery for unoperated coarctation of the aorta. Circulation 1993; 87:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/33\">",
"      Mendelsohn AM, Lloyd TR, Crowley DC, et al. Late follow-up of balloon angioplasty in children with a native coarctation of the aorta. Am J Cardiol 1994; 74:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/34\">",
"      Huggon IC, Qureshi SA, Baker EJ, Tynan M. Effect of introducing balloon dilation of native aortic coarctation on overall outcome in infants and children. Am J Cardiol 1994; 73:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/35\">",
"      Saba SE, Nimri M, Shamaileh Q, et al. Balloon coarctation angioplasty: follow-up of 103 patients. J Invasive Cardiol 2000; 12:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/36\">",
"      Ovaert C, McCrindle BW, Nykanen D, et al. Balloon angioplasty of native coarctation: clinical outcomes and predictors of success. J Am Coll Cardiol 2000; 35:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/37\">",
"      Cowley CG, Orsmond GS, Feola P, et al. Long-term, randomized comparison of balloon angioplasty and surgery for native coarctation of the aorta in childhood. Circulation 2005; 111:3453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/38\">",
"      Rod&eacute;s-Cabau J, Mir&oacute; J, Dancea A, et al. Comparison of surgical and transcatheter treatment for native coarctation of the aorta in patients &gt; or = 1 year old. The Quebec Native Coarctation of the Aorta study. Am Heart J 2007; 154:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/39\">",
"      Hamdan MA, Maheshwari S, Fahey JT, Hellenbrand WE. Endovascular stents for coarctation of the aorta: initial results and intermediate-term follow-up. J Am Coll Cardiol 2001; 38:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/40\">",
"      Chessa M, Carrozza M, Butera G, et al. Results and mid-long-term follow-up of stent implantation for native and recurrent coarctation of the aorta. Eur Heart J 2005; 26:2728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/41\">",
"      Forbes TJ, Moore P, Pedra CA, et al. Intermediate follow-up following intravascular stenting for treatment of coarctation of the aorta. Catheter Cardiovasc Interv 2007; 70:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/42\">",
"      Forbes TJ, Garekar S, Amin Z, et al. Procedural results and acute complications in stenting native and recurrent coarctation of the aorta in patients over 4 years of age: a multi-institutional study. Catheter Cardiovasc Interv 2007; 70:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/43\">",
"      Forbes TJ, Kim DW, Du W, et al. Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). J Am Coll Cardiol 2011; 58:2664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/44\">",
"      Tanous D, Benson LN, Horlick EM. Coarctation of the aorta: evaluation and management. Curr Opin Cardiol 2009; 24:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/45\">",
"      Bruckheimer E, Birk E, Santiago R, et al. Coarctation of the aorta treated with the Advanta V12 large diameter stent: acute results. Catheter Cardiovasc Interv 2010; 75:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/46\">",
"      Chakrabarti S, Kenny D, Morgan G, et al. Balloon expandable stent implantation for native and recurrent coarctation of the aorta--prospective computed tomography assessment of stent integrity, aneurysm formation and stenosis relief. Heart 2010; 96:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/47\">",
"      Kenny D, Cao QL, Kavinsky C, Hijazi ZM. Innovative resource utilization to fashion individualized covered stents in the setting of aortic coarctation. Catheter Cardiovasc Interv 2011; 78:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/48\">",
"      Ringel RE, Gauvreau K, Moses H, Jenkins KJ. Coarctation of the Aorta Stent Trial (COAST): study design and rationale. Am Heart J 2012; 164:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/49\">",
"      Mohan UR, Danon S, Levi D, et al. Stent implantation for coarctation of the aorta in children &lt;30 kg. JACC Cardiovasc Interv 2009; 2:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/50\">",
"      Thanopoulos BD, Giannakoulas G, Giannopoulos A, et al. Initial and six-year results of stent implantation for aortic coarctation in children. Am J Cardiol 2012; 109:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/51\">",
"      Stewart AB, Ahmed R, Travill CM, Newman CG. Coarctation of the aorta life and health 20-44 years after surgical repair. Br Heart J 1993; 69:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/52\">",
"      Rao PS, Chopra PS, Koscik R, et al. Surgical versus balloon therapy for aortic coarctation in infants &lt; or = 3 months old. J Am Coll Cardiol 1994; 23:1479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/53\">",
"      Bacha EA, Almodovar M, Wessel DL, et al. Surgery for coarctation of the aorta in infants weighing less than 2 kg. Ann Thorac Surg 2001; 71:1260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/54\">",
"      Rao PS, Thapar MK, Kutayli F, Carey P. Causes of recoarctation after balloon angioplasty of unoperated aortic coarctation. J Am Coll Cardiol 1989; 13:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/55\">",
"      Patel R, Singh SP, Abrams L, Roberts KD. Coarctation of aorta with special reference to infants. Long-term results of operation in 126 cases. Br Heart J 1977; 39:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/56\">",
"      Messmer BJ, Minale C, M&uuml;hler E, von Bernuth G. Surgical correction of coarctation in early infancy: does surgical technique influence the result? Ann Thorac Surg 1991; 52:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/57\">",
"      Puchalski MD, Williams RV, Hawkins JA, et al. Follow-up of aortic coarctation repair in neonates. J Am Coll Cardiol 2004; 44:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/58\">",
"      Hellenbrand WE, Allen HD, Golinko RJ, et al. Balloon angioplasty for aortic recoarctation: results of Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol 1990; 65:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/59\">",
"      Hijazi ZM, Fahey JT, Kleinman CS, Hellenbrand WE. Balloon angioplasty for recurrent coarctation of aorta. Immediate and long-term results. Circulation 1991; 84:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/60\">",
"      Anjos R, Qureshi SA, Rosenthal E, et al. Determinants of hemodynamic results of balloon dilation of aortic recoarctation. Am J Cardiol 1992; 69:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/61\">",
"      Witsenburg M, The SH, Bogers AJ, Hess J. Balloon angioplasty for aortic recoarctation in children: initial and follow up results and midterm effect on blood pressure. Br Heart J 1993; 70:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/62\">",
"      Magee AG, Brzezinska-Rajszys G, Qureshi SA, et al. Stent implantation for aortic coarctation and recoarctation. Heart 1999; 82:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/63\">",
"      Harrison DA, McLaughlin PR, Lazzam C, et al. Endovascular stents in the management of coarctation of the aorta in the adolescent and adult: one year follow up. Heart 2001; 85:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/64\">",
"      Kpodonu J, Ramaiah VG, Rodriguez-Lopez JA, Diethrich EB. Endovascular management of recurrent adult coarctation of the aorta. Ann Thorac Surg 2010; 90:1716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/65\">",
"      Oliver JM, Gallego P, Gonzalez A, et al. Risk factors for aortic complications in adults with coarctation of the aorta. J Am Coll Cardiol 2004; 44:1641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/66\">",
"      von Kodolitsch Y, Aydin MA, Koschyk DH, et al. Predictors of aneurysmal formation after surgical correction of aortic coarctation. J Am Coll Cardiol 2002; 39:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/67\">",
"      Walhout RJ, Suttorp MJ, Mackaij GJ, et al. Long-term outcome after balloon angioplasty of coarctation of the aorta in adolescents and adults: Is aneurysm formation an issue? Catheter Cardiovasc Interv 2009; 73:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/68\">",
"      Pourmoghadam KK, Velamoor G, Kneebone JM, et al. Changes in protein distribution of the aortic wall following balloon aortoplasty for coarctation. Am J Cardiol 2002; 89:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/69\">",
"      Isner JM, Donaldson RF, Fulton D, et al. Cystic medial necrosis in coarctation of the aorta: a potential factor contributing to adverse consequences observed after percutaneous balloon angioplasty of coarctation sites. Circulation 1987; 75:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/70\">",
"      Moodie DS. Aortic dissection and coarctation. Curr Opin Cardiol 1990; 5:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/71\">",
"      Nistri S, Sorbo MD, Marin M, et al. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart 1999; 82:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/72\">",
"      Hahn RT, Roman MJ, Mogtader AH, Devereux RB. Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am Coll Cardiol 1992; 19:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/73\">",
"      Cramer JW, Ginde S, Bartz PJ, et al. Aortic aneurysms remain a significant source of morbidity and mortality after use of Dacron(&reg;) patch aortoplasty to repair coarctation of the aorta: results from a single center. Pediatr Cardiol 2013; 34:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/74\">",
"      Ince H, Petzsch M, Rehders T, et al. Percutaneous endovascular repair of aneurysm after previous coarctation surgery. Circulation 2003; 108:2967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/75\">",
"      Kutty S, Greenberg RK, Fletcher S, et al. Endovascular stent grafts for large thoracic aneurysms after coarctation repair. Ann Thorac Surg 2008; 85:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/76\">",
"      Cohen M, Fuster V, Steele PM, et al. Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation 1989; 80:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/77\">",
"      Smith Maia MM, Cort&ecirc;s TM, Parga JR, et al. Evolutional aspects of children and adolescents with surgically corrected aortic coarctation: clinical, echocardiographic, and magnetic resonance image analysis of 113 patients. J Thorac Cardiovasc Surg 2004; 127:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/78\">",
"      Toro-Salazar OH, Steinberger J, Thomas W, et al. Long-term follow-up of patients after coarctation of the aorta repair. Am J Cardiol 2002; 89:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/79\">",
"      Clarkson PM, Nicholson MR, Barratt-Boyes BG, et al. Results after repair of coarctation of the aorta beyond infancy: a 10 to 28 year follow-up with particular reference to late systemic hypertension. Am J Cardiol 1983; 51:1481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/80\">",
"      Simsolo R, Grunfeld B, Gimenez M, et al. Long-term systemic hypertension in children after successful repair of coarctation of the aorta. Am Heart J 1988; 115:1268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/81\">",
"      Kimball TR, Reynolds JM, Mays WA, et al. Persistent hyperdynamic cardiovascular state at rest and during exercise in children after successful repair of coarctation of the aorta. J Am Coll Cardiol 1994; 24:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/82\">",
"      Gardiner HM, Celermajer DS, Sorensen KE, et al. Arterial reactivity is significantly impaired in normotensive young adults after successful repair of aortic coarctation in childhood. Circulation 1994; 89:1745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/83\">",
"      Senzaki H, Iwamoto Y, Ishido H, et al. Ventricular-vascular stiffening in patients with repaired coarctation of aorta: integrated pathophysiology of hypertension. Circulation 2008; 118:S191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/84\">",
"      Roifman I, Therrien J, Ionescu-Ittu R, et al. Coarctation of the aorta and coronary artery disease: fact or fiction? Circulation 2012; 126:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/85\">",
"      Verheugt CL, Uiterwaal CS, Grobbee DE, Mulder BJ. Long-term prognosis of congenital heart defects: a systematic review. Int J Cardiol 2008; 131:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/86\">",
"      Puranik R, Tsang VT, Puranik S, et al. Late magnetic resonance surveillance of repaired coarctation of the aorta. Eur J Cardiothorac Surg 2009; 36:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/87\">",
"      Therrien J, Thorne SA, Wright A, et al. Repaired coarctation: a \"cost-effective\" approach to identify complications in adults. J Am Coll Cardiol 2000; 35:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/88\">",
"      Graham TP Jr, Driscoll DJ, Gersony WM, et al. Task Force 2: congenital heart disease. J Am Coll Cardiol 2005; 45:1326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/89\">",
"      Beauchesne LM, Connolly HM, Ammash NM, Warnes CA. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol 2001; 38:1728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/90\">",
"      Deal K, Wooley CF. Coarctation of the aorta and pregnancy. Ann Intern Med 1973; 78:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/91\">",
"      Saidi AS, Bezold LI, Altman CA, et al. Outcome of pregnancy following intervention for coarctation of the aorta. Am J Cardiol 1998; 82:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/92\">",
"      Vriend JW, Drenthen W, Pieper PG, et al. Outcome of pregnancy in patients after repair of aortic coarctation. Eur Heart J 2005; 26:2173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/93\">",
"      Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007; 49:2303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/94\">",
"      Anderson RA, Fineron PW. Aortic dissection in pregnancy: importance of pregnancy-induced changes in the vessel wall and bicuspid aortic valve in pathogenesis. Br J Obstet Gynaecol 1994; 101:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/95\">",
"      Tennant PW, Pearce MS, Bythell M, Rankin J. 20-year survival of children born with congenital anomalies: a population-based study. Lancet 2010; 375:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/96\">",
"      Engelfriet P, Boersma E, Oechslin E, et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2005; 26:2325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/27/20922/abstract/97\">",
"      Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. Second of two parts. N Engl J Med 2000; 342:334.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5784 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-E943584887-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20922=[""].join("\n");
var outline_f20_27_20922=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Critical coarctation in infancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Indications for intervention for noncritical presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H71184637\">",
"      - Adults",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H76537944\">",
"      - Children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Timing of repair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PROCEDURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Balloon angioplasty",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4015728\">",
"      - Native coarctation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Balloon angioplasty versus surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4016665\">",
"      - Recoarctation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Stent placement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MANAGEMENT APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3039949\">",
"      Societal guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3039992\">",
"      Our management approach for native coarctation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3040001\">",
"      - Neonates and young infants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3040038\">",
"      - Older infants and young children",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3040169\">",
"      - Older children and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      LONG-TERM CARDIOVASCULAR OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Recoarctation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Management of recoarctation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3040617\">",
"      Indications for intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3041716\">",
"      Percutaneous intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Aortic aneurysm, dissection, and rupture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Systemic hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5018111\">",
"      Other cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H76537619\">",
"      LONG-TERM MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H76537727\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5687186\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H76537865\">",
"      Endocarditis prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Physical activity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Competitive sports",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Recreational sports",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Unrepaired coarctation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Repaired coarctation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Pregnancy outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      LONG-TERM SURVIVAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5784\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5784|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/51/29489\" title=\"figure 1\">",
"      Classification exercise",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=related_link\">",
"      Clinical manifestations and diagnosis of bicuspid aortic valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=related_link\">",
"      Clinical manifestations and diagnosis of coarctation of the aorta",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33482?source=related_link\">",
"      Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/54/25449?source=related_link\">",
"      Management of aortic dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32330?source=related_link\">",
"      Overview of hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/43/41649?source=related_link\">",
"      Patient information: Aortic coarctation in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/47/25329?source=related_link\">",
"      Patient information: Aortic coarctation in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/25/27032?source=related_link\">",
"      Pregnancy in women with a bicuspid aortic valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/23/37240?source=related_link\">",
"      Thoracic endovascular aneurysm repair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7078?source=related_link\">",
"      Treatment of bicuspid aortic valve stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27626?source=related_link\">",
"      Treatment of hypertension in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_27_20923="Horners syndrome in children";
var content_f20_27_20923=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F69658&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F69658&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Etiology of Horner's syndrome in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        \"Congenital\" (diagnosed within four weeks after birth)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Birth trauma related",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neuroblastoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idiopathic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Acquired",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neuroblastoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rhabdomyosarcoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Brainstem vascular malformations (AVM)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Brainstem tumors (glioma)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Demyelination (brainstem)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carotid artery thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neck trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Post surgical:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Jugular cannulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Thoracic surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Neck surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idiopathic",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20923=[""].join("\n");
var outline_f20_27_20923=null;
var title_f20_27_20924="Causes intra- and extra-vascular hemolysis";
var content_f20_27_20924=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F72394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F72394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common causes of intravascular and extravascular hemolysis in the adult",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Extravascular destruction of red blood cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Intrinsic red blood cell defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Enzyme deficiencies (eg, G6PD or pyruvate kinase deficiencies)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hemoglobinopathies (eg, sickle cell disease, thalassemias, unstable hemoglobins)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Membrane defects (eg, hereditary spherocytosis, elliptocytosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Extrinsic red blood cell defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Liver disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypersplenism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Infections (eg, bartonella, babesia, malaria)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Oxidant agents (eg, dapsone, nitrites, aniline dyes)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Other agents (eg, lead, copper, snake and spider bites)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Large granular lymphocyte leukemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Autoimmune hemolytic anemia (warm- or cold-reacting, drugs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intravenous immune globulin infusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Intravascular destruction of red blood cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Microangiopathy (eg, aortic stenosis, prosthetic valve leak)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transfusion reactions (eg, ABO incompatibility)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infection (eg, clostridial sepsis, severe malaria)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Paroxysmal cold hemoglobinuria; cold agglutinin disease (on occasion)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Paroxysmal nocturnal hemoglobinuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Following intravenous infusion of Rho(D) immune globulin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Following intravenous infusion with hypotonic solutions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Snake bites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Exposure to compounds with high oxidant potential (eg, copper in Wilson's disease)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20924=[""].join("\n");
var outline_f20_27_20924=null;
var title_f20_27_20925="DPD excretion in osteoporosis";
var content_f20_27_20925=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F80253&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F80253&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Increased urinary deoxypyridinoline excretion in osteoporosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 375px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Values for urinary excretion of deoxypyridinoline (DPD), relative to creatinine, in age-matched normal women (Group 1), women with osteoporosis or previous fractures (Group 2), and women with severe osteoporosis (Group 3). Although there was overlap, urinary DPD excretion was higher in the women with osteoporosis, especially those with severe disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: McLaren AM, Hordon LD, Bird HA, Robins SP. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture. Ann Rheum Dis 1992; 51:648.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20925=[""].join("\n");
var outline_f20_27_20925=null;
var title_f20_27_20926="Risk of perinatal death in terms of BPS and GA";
var content_f20_27_20926=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78999&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78999&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Comparison of neonatal death rates as predicted by gestational age and fetal death rates as predicted by the fetal biophysical profile (BPS)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 360px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The red line represents the probability of neonatal death by gestational age. For example, the risk of fetal death with a BPS of 2/10 is approximately 20 percent. Therefore, when the BPS is 2/10, the risk of neonatal death is less than the risk of fetal death if the gestational age is greater than 28 weeks. This graph should be used for illustration only because the neonatal survival rate shown here from the University of Manitoba may differ from other centers. However, the predictive accuracy of the BPS is unlikely to vary among centers.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from data published in: Manning, FA. Dynamic ultrasound-based fetal assessment: the fetal biophysical profile score. Clin obstet Gynecol 1995; 38:26.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_27_20926=[""].join("\n");
var outline_f20_27_20926=null;
var title_f20_27_20927="Contents: Pediatric immunology";
var content_f20_27_20927=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric immunology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric immunology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Antibody deficiencies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/52/21321\">",
"           Agammaglobulinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/28/17866\">",
"           Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/60/13258\">",
"           IgG subclass deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/16/35078\">",
"           IgG subclasses: Physical properties, genetics, and biologic functions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/29/9688\">",
"           Pathogenesis of common variable immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/63/24570\">",
"           Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/11/42168\">",
"           Selective IgM deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/51/17209\">",
"           Selective antibody deficiency with normal immunoglobulins",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/36/41544\">",
"           Transient hypogammaglobulinemia of infancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cellular immunity",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/53/25432\">",
"           Antigen presenting cells",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/38/5735\">",
"           Apoptosis and autoimmune disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/22/36201\">",
"           Immunology of the maternal-fetal interface",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/22/44393\">",
"           Mast cells: Development, identification, and physiologic roles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/54/37733\">",
"           T cell receptor genetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/58/41897\">",
"           T helper subsets: Differentiation and role in disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/58/6056\">",
"           The adaptive cellular immune response",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/54/23401\">",
"           Toll-like receptors: Roles in disease and therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Chromosomal breakage syndromes associated with immunodeficiency",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/42/35493\">",
"           Bloom syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/27/439\">",
"           Nijmegen breakage syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Combined immunodeficiency",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/27/2488\">",
"           Adenosine deaminase deficiency: Pathogenesis, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/43/27320\">",
"           Adenosine deaminase deficiency: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/58/40873\">",
"           Combined immunodeficiencies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/27/8633\">",
"           Medical management of immune deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/2/25637\">",
"           Purine nucleoside phosphorylase deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/52/15176\">",
"           Severe combined immunodeficiency (SCID) with JAK3 deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/30/42471\">",
"           Severe combined immunodeficiency (SCID): An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/0/10\">",
"           Severe combined immunodeficiency (SCID): Specific defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/56/20362\">",
"           T cell negative, B cell negative, NK cell positive severe combined immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/26/25001\">",
"           T cell receptor signaling",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/18/1316\">",
"           X-linked severe combined immunodeficiency (SCID)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/2/42022\">",
"           ZAP-70 deficiency",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cytokines and inflammation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/42/38569\">",
"           Acute phase reactants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/57/3992\">",
"           Overview of autoimmunity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/8/4231\">",
"           Role of cytokines in the immune system",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         HLA",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/38/24167\">",
"           Human leukocyte antigens (HLA): A roadmap",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/41/27283\">",
"           Major histocompatibility complex (MHC) structure and function",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Humoral immunity",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/52/21321\">",
"           Agammaglobulinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/53/40792\">",
"           Function and clinical applications of immunoglobulins",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/12/16585\">",
"           Immunity of the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/52/37702\">",
"           Immunoglobulin genetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/48/24326\">",
"           Primary humoral immune deficiencies: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/9/7318\">",
"           Structure of immunoglobulins",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/62/27624\">",
"           The humoral immune response",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Immunodeficiency disorders - General considerations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/6/23656\">",
"           Flow cytometry for the diagnosis of primary immunodeficiencies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/48/14087\">",
"           Immune globulin therapy in primary immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/58/43945\">",
"           Laboratory evaluation of the immune system",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infection issues in the compromised host",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/47/30458\">",
"           Approach to the child with recurrent infections",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/43/3768\">",
"           Hyperimmunoglobulin-D syndrome: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/7/23670\">",
"           Hyperimmunoglobulin-D syndrome: Management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/31/9720\">",
"           Hyperimmunoglobulin-D syndrome: Pathophysiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/8/15494\">",
"           Periodic fever syndromes and other autoinflammatory diseases: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/11/8377\">",
"           Periodic fever with aphthous stomatitis, pharyngitis and adenitis (PFAPA syndrome)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/32/31242\">",
"           The development of immune cells in the fetus and neonate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/56/28551\">",
"           Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other well defined immunodeficiency syndromes",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/51/7992\">",
"           Cartilage-hair hypoplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/12/22729\">",
"           DiGeorge syndrome: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/37/32343\">",
"           DiGeorge syndrome: Epidemiology and pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/15/15608\">",
"           DiGeorge syndrome: Management and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/25/32153\">",
"           Hyperimmunoglobulin E syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/15/25850\">",
"           IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/8/12420\">",
"           Mannose-binding lectin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/14/19690\">",
"           Mannose-binding lectin deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/12/4297\">",
"           Mendelian susceptibility to mycobacterial diseases (MSMD)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/10/30889\">",
"           NK cell deficiency syndromes: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/39/4724\">",
"           NK cell deficiency syndromes: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/29/36313\">",
"           Wiskott-Aldrich syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/38/33384\">",
"           X-linked lymphoproliferative disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Phagocyte disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/18/42278\">",
"           Chediak-Higashi syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/36/10826\">",
"           Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/12/11465\">",
"           Chronic granulomatous disease: Treatment and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/41/17048\">",
"           Determinants of neutrophil movement",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/58/42920\">",
"           Inherited disorders of the complement system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/26/22953\">",
"           Leukocyte adhesion deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/60/14280\">",
"           Myeloperoxidase deficiency and other enzymatic WBC defects causing immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/31/6650\">",
"           Neutrophil functions other than movement",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/37/10838\">",
"           Neutrophil-specific granule deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/2/6185\">",
"           Normal neutrophil development and kinetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/25/10647\">",
"           Overview and clinical assessment of the complement system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/38/43620\">",
"           Primary disorders of phagocytic function: An overview",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Secondary immune deficiency",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/24/7561\">",
"           Secondary immune deficiency due to miscellaneous causes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Secondary immunodeficiency",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/42/28329\">",
"           CD3/T cell receptor complex disorders causing immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/22/40295\">",
"           Syndromic immunodeficiencies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Transplantation immunology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/51/33590\">",
"           Gene therapy for primary immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/2/1066\">",
"           Hematopoietic cell transplantation for primary immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/24/18826\">",
"           Pathogenesis of graft-versus-host disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/27/10682\">",
"           Transplantation immunobiology",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-69C4F6E59F-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f20_27_20927=[""].join("\n");
var outline_f20_27_20927=null;
